Cerebral cysts

G6_CERCYST

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G93 Hospital discharge: ICD-9 — 3480 Cause of death: ICD-10 — G93 Cause of death: ICD-9 — 3480 2 out of 7 registries used, show all original rules.	2436
4. Check minimum number of events None	2436
5. Include endpoints None	2436
6. Filter based on genotype QC (FinnGen only)	2353

Control definitions (FinnGen only)

Control exclude: G6_OTHNEU

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: G90-G99
Name in latin: Aliae morbositates cerebri

NAME	G6_CERCYST
CONTROL_EXCLUDE	G6_OTHNEU
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G93
HD_ICD_9	3480
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G93
COD_ICD_9	3480
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Cerebral cysts based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Postviral fatigue syndrome

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	20739	9226	11265
Only index persons	15721	7529	8192
Unadjusted period prevalence (%)
Whole population	0.29	0.26	0.31
Only index persons	0.30	0.28	0.31
Median age at first event (years)
Whole population	52.04	47.69	55.28
Only index persons	49.56	44.95	53.80

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2353	1322	1031
Unadjusted period prevalence (%)	0.47	0.47	0.47
Median age at first event (years)	49.92	42.47	59.48

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2436: Matched controls
24360

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

G93.2

ICD-10 Finland

Benign intracranial hypertension

4461.7

307.7

389

G93.3

ICD-10 Finland

Postviral fatigue syndrome

173.3

307.7

330

S01EC01

ATC

acetazolamide; systemic

20.2

307.7

306

172

G93.1

ICD-10 Finland

Anoxic brain damage, not elsewhere classified

6013.0

307.7

495

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

39.0

307.7

311

G93.4

ICD-10 Finland

Encephalopathy, unspecified

3796.8

307.7

340

G93.0

ICD-10 Finland

Cerebral cysts

4009.8

307.7

630

H47.1

ICD-10 Finland

Papilloedema, unspecified

68.7

307.7

202

TAB00

NOMESCO Finland

Lumbar puncture

8.7

246.4

336

440

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

5.9

225.9

460

919

AA1AD

NOMESCO Finland

CT of head and brain

3.9

208.3

878

3097

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

4.8

165.8

424

1020

R51.80

ICD-10 Finland

Headache

3.5

148.3

650

2289

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

17.7

140.0

115

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

4.7

137.8

360

875

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

7.2

120.6

186

276

XA800

NOMESCO Finland

Neuropsychological investigation

5.9

114.1

218

402

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

17.7

108.7

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.1

103.2

518

1940

WX730

NOMESCO Finland

Conventional respirator

11.7

98.1

102

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.9

96.8

573

2345

N03AX11

ATC

topiramate; oral

6.7

96.6

158

249

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

4.7

95.4

235

540

N03AX14

ATC

levetiracetam; systemic

6.6

94.2

156

249

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

15.0

86.4

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

7.2

86.0

131

191

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

295.0

84.2

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

4.1

82.7

241

629

G93.6

ICD-10 Finland

Cerebral oedema

+∞

76.5

G93.99

ICD-10 Finland

Disorder of brain, unspecified

750.7

74.6

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

4.0

74.2

224

599

XCK00

NOMESCO Finland

Perimetry

4.1

73.6

215

561

G93.8

ICD-10 Finland

Other specified disorders of brain

373.3

73.1

R53

ICD-10 Finland

Malaise and fatigue

2.3

72.1

708

3632

A07AA11

ATC

rifaximin; oral

25.5

71.4

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

7.2

70.6

107

155

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.4

70.2

283

918

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.9

68.6

375

1450

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.5

68.2

254

783

R56.8

ICD-10 Finland

Other and unspecified convulsions

4.0

67.6

205

549

N06AX16

ATC

venlafaxine; oral

2.6

67.5

465

2023

N03AG01

ATC

valproic acid; systemic, rectal

3.6

65.1

232

694

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

10.3

63.9

N03AF02

ATC

oxcarbazepine; oral

4.9

63.3

145

312

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

6.4

58.0

159

N05AH04

ATC

quetiapine; oral

2.3

57.3

547

2739

F48.0

ICD-10 Finland

Neurasthenia

23.9

55.7

G40.9

ICD-10 Finland

Epilepsy, unspecified

4.5

55.5

141

330

G93.90

ICD-10 Finland

Brain death

+∞

55.4

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

4.3

54.4

145

352

N03AX18

ATC

lacosamide; systemic

10.8

52.5

N03AX12

ATC

[U] gabapentin; oral

2.4

52.2

433

2033

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

5.5

51.3

101

190

N03AX16

ATC

[U] pregabalin

2.2

51.1

575

3060

Z01.8

ICD-10 Finland

Other specified special examinations

2.1

50.5

603

3281

R68.88

ICD-10 Finland

Other specified general symptoms and signs, not elsewhere classified.

9.7

49.6

WX872

NOMESCO Finland

Intensive care

3.7

49.0

163

464

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

132.8

49.0

R42

ICD-10 Finland

Dizziness and giddiness

2.1

48.4

539

2849

G44.2

ICD-10 Finland

Tension-type headache

2.4

48.4

402

1884

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

4.5

47.8

119

274

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

8.5

47.6

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

7.0

47.1

105

C03CA01

ATC

furosemide; systemic

2.0

47.0

635

3602

N05BA09

ATC

clobazam; oral

11.1

46.9

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.4

46.7

385

1797

N06AX21

ATC

duloxetine; oral

2.5

45.8

335

1481

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.3

45.3

403

1942

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.9

45.1

232

860

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.4

45.0

173

541

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

44.9

1021

6859

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

7.5

44.6

Z2445

NOMESCO Finland

Psychologist

3.5

44.4

161

485

CS494

NOMESCO Finland

Other visual field testing

5.2

44.4

185

G41.9

ICD-10 Finland

Status epilepticus, unspecified

13.9

44.3

N06AX11

ATC

mirtazapine; oral

1.9

44.0

835

5293

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.7

43.7

248

968

N06AB04

ATC

citalopram; systemic

2.1

43.7

531

2890

G43.9

ICD-10 Finland

Migraine, unspecified

2.9

43.6

224

829

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

435.2

43.3

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.3

42.0

361

1711

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.7

41.9

244

964

G93.5

ICD-10 Finland

Compression of brain

+∞

41.8

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

+∞

41.8

N05BA04

ATC

oxazepam; oral

1.9

41.7

654

3885

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

5.2

41.6

173

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

41.5

679

4089

C07AB07

ATC

bisoprolol; oral

1.8

41.1

1027

7046

R41.0

ICD-10 Finland

Disorientation, unspecified

4.8

41.0

206

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.7

40.7

229

889

N03AX09

ATC

lamotrigine; oral

3.1

40.5

182

625

C07AA05

ATC

propranolol; systemic

2.0

39.0

544

3096

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

9.2

38.7

3480A

ICD-9 Finland

Other conditions of brain, Cerebral cysts

+∞

38.6

R4150

NOMESCO Finland

Neuropsychological rehabilitation

8.6

38.3

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

7.2

38.2

N05BA01

ATC

diazepam; systemic, rectal

2.3

37.7

330

1572

G43.3

ICD-10 Finland

Complicated migraine

4.9

37.6

173

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.5

37.2

246

1034

A06AD11

ATC

lactulose; oral

2.2

37.0

342

1665

N03AE01

ATC

clonazepam; systemic

3.0

36.3

166

575

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.8

35.9

194

737

GBB00

NOMESCO Finland

Tracheostomy

6.9

35.7

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

352.2

35.0

N28

ICPC

Limited function/disability (N)

5.6

34.9

123

183

Kela drug reimbursment

Lamotrigin and topiramate

7.2

34.8

G91.1

ICD-10 Finland

Obstructive hydrocephalus

+∞

34.5

H53.1

ICD-10 Finland

Subjective visual disturbances

2.8

34.2

177

657

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

5.4

33.0

126

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.0

32.9

409

2222

H53.4

ICD-10 Finland

Visual field defects

5.0

32.7

142

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.3

32.5

258

1176

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.3

32.4

269

1249

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.6

32.3

203

831

N05CF01

ATC

zopiclone; oral

1.8

32.0

713

4655

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

4.5

31.9

181

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

5.0

31.8

138

N29

ICPC

Neurological sympt/complt other

4.8

31.6

150

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.0

31.4

146

510

G91.0

ICD-10 Finland

Communicating hydrocephalus

+∞

31.3

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

31.3

373

1995

M03BX01

ATC

baclofen; systemic

4.7

31.1

156

AAF99

NOMESCO Finland

Other shunt operation on ventricle of brain or intracerebral cyst

316.8

30.9

N06AB10

ATC

escitalopram; oral

1.8

30.9

548

3342

L28

ICPC

Limited function/disability (L)

2.0

30.8

375

2020

SPAT1301

SPAT

No procedures

1.7

30.7

723

4785

H02AB09

ATC

hydrocortisone; systemic

4.0

30.5

222

C03DA01

ATC

spironolactone; oral

2.2

30.5

272

1301

N06AX12

ATC

bupropion; oral

2.4

30.2

233

1047

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

+∞

29.2

R50.9

ICD-10 Finland

Fever, unspecified

1.9

29.1

400

2243

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.2

28.9

118

382

WX930

NOMESCO Finland

Thepapeutic hypothermia

44.3

28.7

N03AF01

ATC

carbamazepine; oral, rectal

2.9

28.5

136

482

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

28.2

501

3047

M35.7

ICD-10 Finland

Hypermobility syndrome

4.8

27.6

131

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

6.8

27.6

N04BC09

ATC

rotigotine; transdermal

11.3

27.6

R55

ICD-10 Finland

Syncope and collapse

2.2

27.5

252

1216

N06AB06

ATC

sertraline; oral

2.0

27.4

312

1636

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

27.4

356

1956

N02AX02

ATC

tramadol; systemic, rectal

1.6

27.4

929

6716

A28

ICPC

Limited function/disability NOS

2.0

27.2

333

1792

PA2AD

NOMESCO Finland

CT angiography of brain

7.8

26.8

H53.2

ICD-10 Finland

Diplopia

3.5

26.8

282

YKA02

NOMESCO Finland

Excision of kidneys from cadaver donor

274.0

26.8

3007

Kela drug reimbursment

Erenumab and fremanezumab

4.8

26.7

127

R06.0

ICD-10 Finland

Dyspnoea

1.7

26.3

583

3770

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.8

26.1

137

511

WX882

NOMESCO Finland

High dependency care

3.5

25.8

269

R11

ICD-10 Finland

Nausea and vomiting

2.2

25.8

229

1091

N06AX26

ATC

vortioxetine; oral

2.3

25.6

214

995

R51

ICD-10 Finland

Headache

2.5

25.5

166

690

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

6.0

25.1

G47.3

ICD-10 Finland

Sleep apnoea

1.8

25.0

491

3062

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

7.3

24.6

H02AB06

ATC

prednisolone; systemic

1.6

24.5

1048

7941

R18

ICD-10 Finland

Ascites

4.4

24.4

145

M79.7

ICD-10 Finland

Fibromyalgia

3.2

24.4

320

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.5

24.2

241

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.6

24.2

144

573

I46.9

ICD-10 Finland

Cardiac arrest, unspecified

9.8

24.1

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

20.9

23.9

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

68.1

23.8

N06AX22

ATC

agomelatine; oral

3.5

23.8

244

A04

ICPC

Weakness/tiredness general

1.8

23.8

370

2151

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.9

23.6

110

385

E66.8

ICD-10 Finland

Other obesity

2.5

23.6

155

647

A02BC02

ATC

pantoprazole; systemic

1.5

23.5

1469

12059

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

23.3

538

3501

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.9

23.2

177

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

3.7

23.2

205

N05AX08

ATC

risperidone; systemic

2.2

23.1

205

975

SPAT1229

SPAT

Assessment of need for aid

2.4

22.7

163

708

N18

ICPC

Paralysis/weakness

4.5

22.7

124

R4120

NOMESCO Finland

Occupational therapy

2.4

22.4

158

681

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.3

22.3

176

798

AAF00

NOMESCO Finland

Ventriculostomy

21.6

22.1

Z2446

NOMESCO Finland

Social worker

2.3

22.1

183

846

A03FA01

ATC

metoclopramide; systemic, rectal

1.7

22.0

484

3105

G91.8

ICD-10 Finland

Other hydrocephalus

+∞

21.9

TPH07

NOMESCO Finland

Cathetrisation of artery

2.1

21.9

233

1189

G41.2

ICD-10 Finland

Complex partial status epilepticus

63.1

21.9

S06.0

ICD-10 Finland

Concussion

2.0

21.8

264

1410

E66.01

ICD-10 Finland

Obesity due to excess calories

2.0

21.8

243

1262

AA1AA

NOMESCO Finland

Head X-ray examination

7.8

21.7

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.5

21.6

144

605

TK800

NOMESCO Finland

Hemodialysis

3.8

21.6

173

WX704

NOMESCO Finland

Intubation

2.2

21.5

190

902

N05AH03

ATC

olanzapine; systemic

2.3

21.4

172

785

G44.8

ICD-10 Finland

Other specified headache syndromes

4.1

21.4

143

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

7.9

21.3

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

4.5

21.3

114

C07AB02

ATC

metoprolol; systemic

1.8

21.2

387

2356

G45.3

ICD-10 Finland

Amaurosis fugax

50.5

21.1

K90

ICPC

Stroke/cerebrovascular accident

3.7

21.0

190

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.6

20.9

191

N99

ICPC

Neurological disease other

5.1

20.7

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.2

20.7

185

882

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

20.7

460

2955

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

111.0

20.6

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

7.0

20.4

N01

ICPC

Headache

1.8

20.3

318

1848

A02BC05

ATC

esomeprazole; systemic

1.5

20.3

852

6357

U09.9

ICD-10 Finland

Post COVID-19 condition, unspecified

5.1

20.3

ZXY02

NOMESCO Finland

Neuropsychologist

7.6

20.0

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.0

19.8

215

1104

YJA10

NOMESCO Finland

Excision of liver from cadaver donor

+∞

19.8

G90.8

ICD-10 Finland

Other disorders of autonomic nervous system

105.9

19.6

H03AA01

ATC

levothyroxine sodium; systemic

1.6

19.6

482

3174

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

7.8

19.6

A41.9

ICD-10 Finland

Sepsis, unspecified

2.9

19.5

314

N06BA07

ATC

modafinil; oral

8.4

19.3

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

19.3

829

6200

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.4

19.2

212

B03BA03

ATC

hydroxocobalamin; parenteral

2.5

19.0

119

486

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

4.7

18.9

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

18.9

306

1793

G40.10

ICD-10 Finland

Simple partial seizures

6.6

18.8

K72.9

ICD-10 Finland

Hepatic failure, unspecified

7.4

18.7

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.4

18.6

131

565

ZXD05

NOMESCO Finland

Urgent procedure

1.5

18.5

701

5096

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.6

18.5

105

409

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.9

18.1

299

127

Kela drug reimbursment

Transplant complication

4.1

18.1

125

N04BC05

ATC

pramipexole; oral

2.2

18.1

162

773

J01FF01

ATC

clindamycin; systemic

1.6

18.1

579

4051

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.9

18.1

294

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.4

18.0

121

510

WX892

NOMESCO Finland

Monitored bed care

2.1

18.0

167

808

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

4.2

18.0

117

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

18.0

247

1375

R51.81

ICD-10 Finland

Facial pain NOS

3.3

17.9

201

R20.2

ICD-10 Finland

Paraesthesia of skin

2.2

17.9

164

790

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

3.1

17.8

238

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

5.7

17.7

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

4.0

17.7

123

G95.0

ICD-10 Finland

Syringomyelia and syringobulbia

95.8

17.6

I47.2

ICD-10 Finland

Ventricular tachycardia

3.6

17.6

160

R52.9

ICD-10 Finland

Pain, unspecified

1.9

17.5

220

1188

AAF40

NOMESCO Finland

Shunt of cyst of brain to peritoneum

181.3

17.5

N02BF02

ATC

pregabalin; oral

2.3

17.5

131

580

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

5.3

17.5

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.4

17.5

122

524

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.1

17.4

173

859

SPAT1255

SPAT

Intravenous administration of medicine

2.2

17.4

151

711

N02CD02

ATC

galcanezumab; parenteral

7.8

17.4

XA400

NOMESCO Finland

EEG

7.1

17.4

A98

ICPC

Health maint/preventive medicine

0.6

17.4

2071

22059

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

17.3

214

1149

R1250

NOMESCO Finland

Evaluation of functional capability

3.4

17.3

186

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.1

17.2

163

795

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

17.2

556

3894

WX900

NOMESCO Finland

Resuscitation

17.5

16.9

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

16.9

317

1938

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

+∞

16.7

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.7

16.7

359

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

16.5

544

3819

R4190

NOMESCO Finland

Nutritional therapy

2.5

16.5

106

438

AAF15

NOMESCO Finland

Ventriculoatrial shunt

171.1

16.5

Z3231

NOMESCO Finland

Registered nurse

1.5

16.3

580

4140

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

16.2

263

1540

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

3.8

16.1

127

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

16.0

257

1499

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.8

16.0

283

1698

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

3.3

16.0

190

XF404

NOMESCO Finland

Ambulatory ECG

2.0

15.9

178

923

N06AA10

ATC

nortriptyline; systemic

3.3

15.9

186

Z02.7

ICD-10 Finland

Issue of medical certificate

2.1

15.9

164

827

K70.4

ICD-10 Finland

Alcoholic hepatic failure

12.3

15.8

N05AX12

ATC

aripiprazole; systemic

2.3

15.8

120

535

A02BC01

ATC

omeprazole; systemic

1.5

15.8

551

3915

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

3.9

15.7

120

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.0

15.7

187

992

G40

ICD-10 Finland

Epilepsy

4.9

15.7

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

15.7

394

2596

AAF10

NOMESCO Finland

Lumboperitoneal shunt

+∞

15.6

G93.9

ICD-10 Finland

Disorder of brain, unspecified

+∞

15.6

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

15.6

232

1322

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.1

15.6

144

695

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

15.6

201

1094

PA7BD

NOMESCO Finland

CT angiography of neck and brain

5.3

15.6

Q04.6

ICD-10 Finland

Congenital cerebral cysts

85.6

15.6

K72.1

ICD-10 Finland

Chronic hepatic failure

22.2

15.5

ZX120

NOMESCO Finland

Intravenous

1.9

15.4

201

1099

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.8

15.4

281

L04AA06

ATC

mycophenolic acid; systemic

3.5

15.4

155

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

3.5

15.4

155

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.4

15.4

160

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

15.4

178

935

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

15.3

563

4041

R40.2

ICD-10 Finland

Coma, unspecified

5.9

15.3

L04AD02

ATC

tacrolimus; systemic

4.4

15.2

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

4.5

15.2

R13

ICD-10 Finland

Dysphagia

2.1

15.2

147

723

N02CD03

ATC

fremanezumab; systemic

4.2

15.1

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

4.3

15.0

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.6

15.0

343

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

6.5

14.9

N07AA02

ATC

pyridostigmine; systemic

6.8

14.9

N06AA09

ATC

amitriptyline; systemic

1.9

14.7

179

956

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

4.1

14.7

SPAT1263

SPAT

Sampling

1.4

14.7

918

7283

SPAT1240

SPAT

Therapeutic discussion

1.7

14.6

272

1655

G50.1

ICD-10 Finland

Atypical facial pain

3.6

14.6

136

G97.1

ICD-10 Finland

Other reaction to spinal and lumbar puncture

+∞

14.6

R4110

NOMESCO Finland

Physiotherapy

1.5

14.6

556

4016

N05BA06

ATC

lorazepam; systemic, sublingual

2.3

14.5

113

509

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.9

14.5

109

N02AA05

ATC

oxycodone; systemic

1.6

14.4

324

2074

E66.9

ICD-10 Finland

Obesity, unspecified

2.4

14.3

411

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

14.3

346

2255

SPAT1216

SPAT

Assessment of functional ability

1.7

14.3

282

1744

P76

ICPC

Depressive disorder

1.9

14.3

173

923

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

4.4

14.3

P29

ICPC

Psychological sympt/compl other

1.9

14.3

190

1046

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

4.5

14.2

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

14.2

183

996

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.5

14.2

376

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

3.6

14.1

125

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

14.0

155

801

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

14.0

483

3412

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.1

13.9

191

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

5.2

13.9

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

3.0

13.9

202

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.7

13.8

257

1563

C09CA06

ATC

candesartan; oral

1.5

13.8

451

3149

G41.0

ICD-10 Finland

Grand mal status epilepticus

20.2

13.8

N06AB03

ATC

fluoxetine; oral

1.7

13.7

265

1628

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.7

13.7

256

1560

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

13.7

367

2451

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.3

13.6

101

446

P03

ICPC

Feeling depressed

1.7

13.6

257

1571

K91

ICPC

Cerebrovascular disease

4.8

13.5

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.1

13.5

128

625

H47.2

ICD-10 Finland

Optic atrophy

11.0

13.5

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

11.0

13.5

Z3226

NOMESCO Finland

Physiotherapist

1.6

13.5

372

2501

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

6.1

13.4

SPAT1260

SPAT

Consultation of another employee

1.6

13.4

361

2413

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

5.6

13.4

A02BA02

ATC

ranitidine; systemic

1.6

13.3

355

2365

F05.9

ICD-10 Finland

Delirium, unspecified

3.5

13.3

135

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

4.1

13.3

C09AA05

ATC

ramipril; oral

1.5

13.3

429

2986

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

5.8

13.2

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.0

13.2

148

769

N02CD01

ATC

erenumab; parenteral

4.2

13.2

A01

ICPC

Pain general/multiple sites

1.8

13.1

185

1037

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.9

13.1

182

1016

K07.60

ICD-10 Finland

Snapping jaw

2.0

13.0

133

668

N05CD07

ATC

temazepam; oral

1.8

13.0

211

1234

G44.0

ICD-10 Finland

Cluster headache syndrome

3.8

13.0

104

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

13.0

921

7422

I25.2

ICD-10 Finland

Old myocardial infarction

2.1

12.9

126

622

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

12.9

102

463

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

12.8

384

2627

N06AB05

ATC

paroxetine; oral

2.0

12.8

132

665

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

11.6

12.8

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

12.8

657

5007

R03AC02

ATC

salbutamol; inhalant

1.4

12.7

1210

10214

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

12.7

308

2007

ZY010

NOMESCO Finland

Hospital outpatient

2.0

12.6

138

711

N05CD08

ATC

midazolam; nasal, systemic

3.0

12.5

187

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

12.5

417

2918

N89

ICPC

Migraine

2.2

12.5

107

502

G95.8

ICD-10 Finland

Other specified diseases of spinal cord

+∞

12.5

CK2A4

NOMESCO Finland

Autofluorescence imaging of ocular fundus

9.3

12.5

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

3.6

12.4

112

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.9

12.4

199

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.5

12.4

314

N02CC03

ATC

zolmitriptan; nasal, oral

2.0

12.4

135

694

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.9

12.4

150

801

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

12.3

215

1284

J01MA02

ATC

ciprofloxacin; systemic

1.4

12.3

766

6027

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

2.8

12.3

217

M79.1

ICD-10 Finland

Myalgia

1.6

12.3

316

2088

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.8

12.2

200

1172

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.3

12.2

429

K92.0

ICD-10 Finland

Haematemesis

2.8

12.1

207

CS3P4

NOMESCO Finland

Optic nerve head stereophotography

4.6

12.1

AN1

Coronary angiography

1.8

12.0

188

1087

W19

ICD-10 Finland

Unspecified fall

1.8

12.0

201

1186

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

12.0

857

6891

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.4

12.0

356

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.7

11.9

204

1211

L01AX03

ATC

temozolomide; systemic

5.0

11.9

Z3229

NOMESCO Finland

Other healthcare associate professional

1.8

11.9

169

949

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

3.8

11.9

Q04.8

ICD-10 Finland

Other specified congenital malformations of brain

46.9

11.9

H02AB04

ATC

methylprednisolone; systemic

1.6

11.9

275

1770

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.4

11.9

333

G43.8

ICD-10 Finland

Other migraine

3.1

11.8

156

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

5.4

11.8

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.7

11.8

227

A04AA01

ATC

ondansetron; systemic, rectal

1.9

11.8

157

864

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.7

11.8

246

1542

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.2

11.7

462

H47.3

ICD-10 Finland

Other disorders of optic disc

9.0

11.7

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

5.1

11.7

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

11.7

579

4371

N05AB03

ATC

perphenazine; systemic, rectal

2.3

11.6

361

SPAT1153

SPAT

Removal of sutures

1.4

11.6

591

4483

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

12.6

11.6

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

11.6

370

2562

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.9

11.6

146

789

ZYC01

NOMESCO Finland

Remote contact by phone

2.0

11.6

135

711

R52.2

ICD-10 Finland

Other chronic pain

2.3

11.6

368

E23.06

ICD-10 Finland

Empty sella

19.0

11.6

205

Kela drug reimbursment

Chronic hypertension

1.5

11.6

437

3135

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

11.5

389

2727

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.0

11.5

119

601

XCK10

NOMESCO Finland

Photography of fundus of eye

1.8

11.5

180

1042

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

11.5

180

1042

N02BF01

ATC

gabapentin; oral

1.9

11.5

157

872

AAF45

NOMESCO Finland

Fenestration of intracranial cyst

+∞

11.5

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

+∞

11.5

N06AG02

ATC

moclobemide; oral

2.3

11.4

402

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

4.1

11.4

K92.1

ICD-10 Finland

Melaena

2.1

11.4

105

508

N06AX05

ATC

trazodone; oral

2.6

11.4

255

N17

ICPC

Vertigo/dizziness

1.7

11.3

233

1455

K76.7

ICD-10 Finland

Hepatorenal syndrome

15.1

11.3

M54.2

ICD-10 Finland

Cervicalgia

1.8

11.3

172

988

N05AA02

ATC

levomepromazine; systemic

2.2

11.2

418

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

4.3

11.2

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

4.9

11.2

JDB10

NOMESCO Finland

Percutaneous gastrostomy

4.0

11.2

J45.8

ICD-10 Finland

Mixed asthma

2.5

11.2

275

N05AD01

ATC

haloperidol; systemic

2.5

11.2

275

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.0

11.2

118

601

J01EA01

ATC

trimethoprim; systemic

1.4

11.1

497

3678

B01AA03

ATC

warfarin; systemic

1.5

11.1

322

2183

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

11.1

412

2942

Z56.7

ICD-10 Finland

Other and unspecified problems related to employment

8.1

11.1

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

11.1

189

1122

RD210, ,

NOMESCO Finland

2.9

11.0

179

G43.2

ICD-10 Finland

Status migrainosus

5.8

11.0

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.2

11.0

137

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.1

11.0

103

502

F61.0

ICD-10 Finland

Mixed personality disorders

3.0

10.9

153

C07AG02

ATC

carvedilol; oral

2.1

10.9

103

503

F50.9

ICD-10 Finland

Eating disorder, unspecified

3.5

10.9

103

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.6

10.9

255

JJC00

NOMESCO Finland

Allogenic transplantation of liver

12.0

10.8

N04BD01

ATC

selegiline; oral

3.7

10.8

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.6

10.8

244

101

Kela drug reimbursment

Anterior pituitary hypofunction

4.3

10.8

P01

ICPC

Feeling anxious/nervous/tense

1.5

10.8

315

2140

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

4.7

10.7

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.5

10.7

257

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

3.7

10.7

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

10.7

516

3872

N05CF02

ATC

zolpidem; oral

1.5

10.6

343

2381

N30.0

ICD-10 Finland

Acute cystitis

1.5

10.6

318

2172

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

3.0

10.6

156

H57.1

ICD-10 Finland

Ocular pain

2.2

10.5

403

Z94.4

ICD-10 Finland

Liver transplant status

8.5

10.5

A05

ICPC

Feeling ill

1.8

10.5

157

896

B01AC04

ATC

clopidogrel; oral

1.6

10.4

236

1509

UJF92

NOMESCO Finland

Capsular endoscopy

2.7

10.4

196

G92

ICD-10 Finland

Toxic encephalopathy

+∞

10.4

T71

ICD-10 Finland

Asphyxiation

+∞

10.4

YFA50

NOMESCO Finland

Excision of heart for preparation of homograft

+∞

10.4

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

10.3

385

2749

F32.1

ICD-10 Finland

Moderate depressive episode

1.8

10.3

151

857

N03AB02

ATC

phenytoin; systemic

4.0

10.3

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.5

10.3

102

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

10.3

759

6101

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.0

10.3

148

W79

ICD-10 Finland

Inhalation and ingestion of food causing obstruction of respiratory tract

10.6

10.3

G40.4

ICD-10 Finland

Other generalized epilepsy and epileptic syndromes

18.9

10.3

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

10.2

697

5532

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

10.2

692

5487

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

2.1

10.2

101

502

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

10.2

131

713

N02CC05

ATC

almotriptan; oral

2.1

10.2

469

T82

ICPC

Obesity

2.1

10.2

469

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

10.2

112

579

N05BA12

ATC

alprazolam; oral

1.7

10.2

193

1180

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

10.1

647

5084

J01DA01

ATC

[U] cefalexin

1.3

10.1

1321

11525

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

5.0

10.0

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

5.0

10.0

N88

ICPC

Epilepsy

4.8

10.0

LCA06

NOMESCO Finland

Biopsy of endometrium

1.7

10.0

208

1303

SPAT1310

SPAT

Counselling related to known health issue

1.4

10.0

655

5166

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

10.0

256

1688

TKC20

NOMESCO Finland

Catheterisation of bladder

1.9

10.0

126

683

B02AA02

ATC

tranexamic acid; systemic

1.5

9.9

292

1985

SPAT1262

SPAT

Handing over of treatment supplies

1.5

9.9

314

2170

E23.00

ICD-10 Finland

Panhypopituitarism

8.1

9.8

R03DC03

ATC

montelukast; oral

1.5

9.8

341

2401

N30.9

ICD-10 Finland

Cystitis, unspecified

1.9

9.8

119

637

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

4.0

9.8

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

4.7

9.8

H93.1

ICD-10 Finland

Tinnitus

1.9

9.8

132

731

Z08

ICPC

Social welfare problem

3.2

9.7

116

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.7

9.7

198

UJF32

NOMESCO Finland

Coloscopy

1.4

9.7

463

3462

F79.0

ICD-10 Finland

Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour

13.4

9.7

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

9.7

367

2629

AAA20

NOMESCO Finland

Insertion of intraventricular pressure monitoring device

55.2

9.6

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.7

9.6

188

G54.0

ICD-10 Finland

Brachial plexus disorders

2.3

9.6

290

G43

ICD-10 Finland

Migraine

1.8

9.6

137

773

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

4.8

9.5

M54.6

ICD-10 Finland

Pain in thoracic spine

1.8

9.5

156

916

F45.8

ICD-10 Finland

Other somatoform disorders

1.7

9.5

164

977

N18.8

ICD-10 Finland

Other chronic renal failure

2.7

9.5

183

C01CA24

ATC

epinephrine; parenteral

1.8

9.5

147

849

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

9.5

225

1456

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.1

9.5

462

R33

ICD-10 Finland

Retention of urine

1.8

9.4

147

850

R03BA05

ATC

fluticasone; inhalant

1.5

9.4

379

2743

JN4AD

NOMESCO Finland

Body CT examination

1.7

9.4

172

1040

OAB43, ,

SPAT

0.7

9.4

430

5666

G81.9

ICD-10 Finland

Hemiplegia, unspecified

4.1

9.4

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

9.4

230

1498

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.7

9.4

178

F34.1

ICD-10 Finland

Dysthymia

2.1

9.4

429

D33.9

ICD-10 Finland

Benign neoplasm: Central nervous system, unspecified

30.1

9.4

G50.0

ICD-10 Finland

Trigeminal neuralgia

3.1

9.4

129

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.4

9.4

249

R06AE07

ATC

cetirizine; oral

1.3

9.4

934

7817

G91.3

ICD-10 Finland

Post-traumatic hydrocephalus, unspecified

+∞

9.4

G93

ICD-10 Finland

Other disorders of brain

+∞

9.4

P99

ICPC

Psychological disorders other

2.2

9.3

344

P01AB01

ATC

metronidazole; oral, rectal

1.3

9.3

798

6536

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.1

9.3

437

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.9

9.3

113

604

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

8.1

9.3

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

9.3

389

2836

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

9.3

152

892

XCD10

NOMESCO Finland

Electrophysiological examination of eye

2.6

9.3

197

E66.0

ICD-10 Finland

Obesity due to excess calories

4.1

9.2

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

9.2

125

693

ZXA10

NOMESCO Finland

Bilateral

1.5

9.2

337

2396

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

3.5

9.2

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.2

9.2

110

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.7

9.2

175

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.7

9.2

175

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.3

9.1

277

R47.1

ICD-10 Finland

Dysarthria and anarthria

4.3

9.1

SPAT1252

SPAT

Overall medication plan or its review

1.9

9.1

121

667

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.9

9.1

111

595

UKC02

NOMESCO Finland

Cystoscopy

1.5

9.1

276

1888

N02CC04

ATC

rizatriptan; oral

1.8

9.1

127

711

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.4

9.1

253

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

9.1

341

2436

R02

ICPC

Shortness of breath/dyspnoea

1.6

9.1

241

1601

G04.9

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis, unspecified

11.5

9.1

A86

ICD-10 Finland

Unspecified viral encephalitis

8.3

9.1

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

4.0

9.1

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

9.0

265

1799

R06.4

ICD-10 Finland

Hyperventilation

3.0

9.0

132

M54.5

ICD-10 Finland

Low back pain

1.3

9.0

729

5917

D35.4

ICD-10 Finland

Benign neoplasm: Pineal gland

36.8

9.0

J01DB01

ATC

cefalexin; oral

1.4

9.0

1853

17087

WX402

NOMESCO Finland

General anaesthesia

1.4

9.0

420

3125

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

9.0

220

1435

T90.5

ICD-10 Finland

Sequelae of intracranial injury

3.6

8.9

E87.5

ICD-10 Finland

Hyperkalaemia

3.1

8.9

117

R21

ICPC

Throat symptom/complaint

1.4

8.9

499

3826

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.7

8.9

146

857

N06BA04

ATC

methylphenidate; oral

2.0

8.9

101

528

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

2.5

8.9

231

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.7

8.9

147

866

SPAT1050

SPAT

Extensive neurological examination

2.8

8.8

156

X58

ICD-10 Finland

Exposure to other specified factors

1.5

8.8

293

2043

ZXD00

NOMESCO Finland

Emergency procedure

2.2

8.8

340

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.3

8.7

289

XKC03

NOMESCO Finland

Water cystometry

2.5

8.7

215

D64.9

ICD-10 Finland

Anaemia, unspecified

1.7

8.7

176

1094

M03AX01

ATC

botulinum toxin; parenteral

3.0

8.6

125

ZXC95

NOMESCO Finland

Use of surgical navigator

3.3

8.6

U08.9

ICD-10 Finland

Personal history of COVID-19, unspecified

4.4

8.6

L29

ICPC

Musculoskeletal sympt/complt other

1.7

8.6

161

981

H54.7

ICD-10 Finland

Unspecified visual loss

4.8

8.6

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

8.6

223

1474

R4130

NOMESCO Finland

Speech therapy

2.5

8.6

211

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.3

8.6

279

K30

ICD-10 Finland

Functional dyspepsia

1.6

8.6

215

1410

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.7

8.5

157

952

M01AE02

ATC

naproxen; oral, rectal

1.3

8.5

1219

10658

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.9

8.5

109

594

J01MA12

ATC

levofloxacin; systemic

1.4

8.5

335

2414

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.9

8.5

101

537

Z43.0

ICD-10 Finland

Attention to tracheostomy

27.6

8.5

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.5

8.5

230

1536

R52.1

ICD-10 Finland

Chronic intractable pain

3.9

8.4

ABB20

NOMESCO Finland

Drainage of intra- or extramedullary cyst of spinal canal

90.4

8.4

D01

ICPC

Abdominal pain/cramps general

1.5

8.4

249

1694

N06AX03

ATC

mianserin; oral

2.0

8.4

441

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

3.1

8.4

111

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.6

8.4

227

1514

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

3.5

8.4

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

3.4

8.4

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

8.4

453

3453

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.6

8.3

184

G46.3*I67.9

ICD-10 Finland

Brain stem stroke syndrome (I60-I67+)

+∞

8.3

G90.0

ICD-10 Finland

Idiopathic peripheral autonomic neuropathy

+∞

8.3

Z98.2

ICD-10 Finland

Presence of cerebrospinal fluid drainage device

+∞

8.3

WX725

NOMESCO Finland

Noninvasive ventilation

1.9

8.3

105

570

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

8.3

202

1315

N02BE01

ATC

paracetamol; systemic, rectal

1.4

8.3

1947

18156

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.8

8.3

115

644

XX1ZW

NOMESCO Finland

Very extensive written report from radiologist

7.1

8.2

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.1

8.2

336

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

3.2

8.2

102

N93.9

ICD-10 Finland

Abnormal uterine and vaginal bleeding, unspecified

2.4

8.2

234

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

8.2

183

1167

FPJ21

NOMESCO Finland

Revision of cardioverter-defibrillator with ventricular electrode

14.5

8.2

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

4.2

8.2

C10AC01

ATC

colestyramine; oral

2.4

8.2

228

A10AB05

ATC

insulin aspart; parenteral

1.7

8.2

151

917

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.8

8.2

109

602

N05AN01

ATC

lithium; oral

2.3

8.2

253

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.8

8.2

111

617

S00.0

ICD-10 Finland

Superficial injury of scalp

2.5

8.2

192

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.3

8.2

247

H47.0

ICD-10 Finland

Disorders of optic nerve, not elsewhere classified

7.5

8.2

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.4

8.1

229

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.1

8.0

366

M54.1

ICD-10 Finland

Radiculopathy

2.1

8.0

373

M79.6

ICD-10 Finland

Pain in limb

1.3

8.0

813

6786

T78.4

ICD-10 Finland

Allergy, unspecified

1.9

8.0

101

548

R5140, ,

SPAT

4.1

8.0

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.1

8.0

367

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

3.5

8.0

C09AA02

ATC

enalapril; systemic

1.4

7.9

312

2246

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.6

7.9

171

H02AA02

ATC

fludrocortisone; oral

4.3

7.9

J02AC01

ATC

fluconazole; systemic

1.3

7.9

780

6482

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

3.4

7.9

N05AF03

ATC

chlorprothixene; systemic

2.3

7.9

244

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.7

7.9

160

I50.0

ICD-10 Finland

Congestive heart failure

1.8

7.9

115

654

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.7

7.8

149

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

7.8

875

7394

AS7

Arrhythmia pacemaker insertion VVI (R) S

10.8

7.8

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

2.4

7.8

203

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.7

7.7

140

846

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

2.9

7.7

117

B81

ICPC

Anaemia vit B12/folate deficiency

2.2

7.7

286

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

3.4

7.7

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

3.3

7.7

SPAT1312

SPAT

General health counselling

1.3

7.6

656

5348

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

7.6

196

1292

R07.0

ICD-10 Finland

Pain in throat

1.6

7.6

156

974

AAK00

NOMESCO Finland

Cranioplasty

18.4

7.6

A10AE04

ATC

insulin glargine; parenteral

1.6

7.6

179

1157

N05AB04

ATC

prochlorperazine; systemic, rectal

2.7

7.6

146

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

3.6

7.6

SAA04

NOMESCO Finland

Special examination of mouth

1.8

7.6

116

669

E87.6

ICD-10 Finland

Hypokalaemia

2.2

7.6

275

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.0

7.5

396

I67.6

ICD-10 Finland

Nonpyogenic thrombosis of intracranial venous system

10.1

7.5

H52.5

ICD-10 Finland

Disorders of accommodation

10.1

7.5

N05BE01

ATC

buspirone; oral

2.2

7.5

282

Z94.0

ICD-10 Finland

Kidney transplant status

3.2

7.5

SPAT1254

SPAT

Administration of medicine

1.5

7.5

284

2029

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.3

7.5

B34.9

ICD-10 Finland

Viral infection, unspecified

2.1

7.5

342

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

7.5

548

4368

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.4

7.5

219

T91

ICPC

Vitamin/nutritional deficiency

4.2

7.5

N02CC06

ATC

eletriptan; oral

1.9

7.4

447

103

Kela drug reimbursment

Diabetes, insulin-treated

1.4

7.4

450

3486

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.7

7.4

143

879

G90.2

ICD-10 Finland

Horner syndrome

80.3

7.4

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

3.6

7.4

N19

ICPC

Speech disorder

3.0

7.4

109

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.9

7.4

498

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

7.4

113

652

A02BC03

ATC

lansoprazole; oral

1.3

7.4

503

3967

D97

ICPC

Liver disease NOS

6.0

7.4

R25.1

ICD-10 Finland

Tremor, unspecified

2.3

7.4

246

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

7.3

590

4764

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.7

7.3

143

PA2CG

NOMESCO Finland

Extensive MRI examination of vessels in the head with high intensity magnet

8.4

7.3

R41.3

ICD-10 Finland

Other amnesia

2.4

7.3

209

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

7.3

170

1096

G96.0

ICD-10 Finland

Cerebrospinal fluid leak

+∞

7.3

GBB03

NOMESCO Finland

Percutaneous tracheostomy

+∞

7.3

AAA10

NOMESCO Finland

Biopsy through craniotomy

+∞

7.3

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.0

7.3

415

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.3

7.3

222

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

2.5

7.3

185

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.9

7.3

465

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.7

7.3

122

723

J01AA02

ATC

doxycycline; systemic

1.3

7.3

1604

14661

F83

ICD-10 Finland

Mixed specific developmental disorders

3.8

7.3

UJD02

NOMESCO Finland

Gastroscopy

1.9

7.2

466

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.9

7.2

502

SPAT1097

SPAT

Recording of ECG

1.5

7.2

242

1690

E28.2

ICD-10 Finland

Polycystic ovarian syndrome

2.5

7.2

180

F10.24

ICD-10 Finland

Alcohol depence active use

2.8

7.2

122

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

7.1

285

2057

A03CA02

ATC

clidinium and psycholeptics; oral

1.9

7.1

482

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.4

7.1

205

F33.8

ICD-10 Finland

Other recurrent depressive disorders

3.1

7.1

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

7.1

246

1727

D33.02

ICD-10 Finland

Another benign medial tumor of the cerebrum

20.1

7.1

XFE00

NOMESCO Finland

Epicardial ultrasonography

2.6

7.1

157

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

3.3

7.1

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.5

7.1

181

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

7.1

418

3223

AAA27

NOMESCO Finland

Insertion of intracerebral pressure monitoring device

12.1

7.1

A29

ICPC

General symptom/complaint other

1.5

7.1

227

1571

NJ3BG

NOMESCO Finland

MRI examination of extremities with high intensity magnet

8.8

7.0

J96.0

ICD-10 Finland

Acute respiratory failure

3.0

7.0

Q07.0

ICD-10 Finland

Arnold-Chiari syndrome

10.0

7.0

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

7.0

255

1808

F41.00

ICD-10 Finland

Moderate panic disorder

2.4

7.0

182

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.4

7.0

182

A46

ICD-10 Finland

Erysipelas

1.5

7.0

244

1716

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

7.0

111

647

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

7.0

1005

8721

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

3.4

7.0

G47.9

ICD-10 Finland

Sleep disorder, unspecified

2.2

7.0

278

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.2

7.0

265

A08

ICPC

Swelling

1.9

6.9

472

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

6.9

509

4053

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

6.9

524

4190

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.5

6.9

177

PA6AD

NOMESCO Finland

CT of neck arteries

2.5

6.9

165

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.5

6.9

198

1338

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.8

6.9

119

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.6

6.9

164

1063

2152

FHL

Extraction, big brain

13.8

6.9

G62.8

ICD-10 Finland

Other specified polyneuropathies

3.6

6.9

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.7

6.9

109

636

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.7

6.8

120

720

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.2

6.8

254

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.5

6.8

185

1235

A10AC01

ATC

insulin (human); parenteral

1.6

6.8

148

938

H02AB07

ATC

prednisone; oral

1.5

6.8

240

1691

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

6.8

332

2481

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.8

6.8

102

585

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

3.8

6.8

J01CA08

ATC

pivmecillinam; oral

1.3

6.8

771

6498

D33.07

ICD-10 Finland

Colloid coast in cerebral ventricle

11.0

6.8

FPG40

NOMESCO Finland

Replacement of pulse generator in transvenous cardioverter-defibrillator

9.3

6.8

I62.0

ICD-10 Finland

Nontraumatic subdural haemorrhage

6.1

6.8

Z02.4

ICD-10 Finland

Examination for driving licence

0.7

6.8

247

3403

UDC00

NOMESCO Finland

Ear microscopy

1.6

6.7

140

878

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

3.9

6.7

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.4

6.7

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

6.7

256

1834

Q87.88

ICD-10 Finland

Other specified congenital malformation syndromes, not elsewhere classified

22.6

6.7

AAK80

NOMESCO Finland

Partial excision of skull cap

22.6

6.7

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.9

6.7

414

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

6.7

510

4083

E86

ICD-10 Finland

Volume depletion

2.4

6.6

181

H81.4

ICD-10 Finland

Vertigo of central origin

4.0

6.6

G03.9

ICD-10 Finland

Meningitis, unspecified

7.8

6.6

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.7

6.6

122

C01BD01

ATC

amiodarone; systemic

2.3

6.6

200

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.7

6.6

113

674

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.9

6.6

459

C08DB01

ATC

diltiazem; oral

1.9

6.6

409

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

6.6

409

WX722

NOMESCO Finland

PEEP

1.9

6.6

438

R50.8

ICD-10 Finland

Other specified fever

3.8

6.5

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

2.6

6.5

146

A10BA02

ATC

metformin; oral

1.3

6.5

472

3749

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.8

6.5

512

L17

ICPC

Foot/toe symptom/complaint

1.3

6.5

528

4261

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

2.8

6.5

112

Angiography of the heart and coronary arteries

1.8

6.5

542

K76.9

ICD-10 Finland

Liver disease, unspecified

2.9

6.5

101

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

3.7

6.5

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.2

6.5

221

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

6.5

119

724

N02CC07

ATC

frovatriptan; oral

1.8

6.5

550

H52.1

ICD-10 Finland

Myopia

1.9

6.4

419

R60.0

ICD-10 Finland

Localized oedema

1.5

6.4

196

1342

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.9

6.4

448

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.7

6.4

103

603

G90.9

ICD-10 Finland

Disorder of autonomic nervous system, unspecified

70.0

6.4

G46.4*I67.9

ICD-10 Finland

Cerebellar stroke syndrome

70.0

6.4

D44.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pineal gland

70.0

6.4

R52.0

ICD-10 Finland

Acute pain

2.0

6.4

363

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

3.4

6.4

XF402

NOMESCO Finland

ECG with work load test

1.5

6.4

168

1114

XCW12

NOMESCO Finland

Assessment of colour vision

14.3

6.4

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

2.8

6.4

113

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

2.8

6.4

113

XG466

NOMESCO Finland

Sleep oxymetry

2.1

6.4

275

A07AA02

ATC

nystatin; oral

1.8

6.4

545

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

3.7

6.4

WX890

NOMESCO Finland

Intesive care monitoring

3.7

6.4

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.5

6.4

148

F54

ICD-10 Finland

Psychological and behavioural factors associated with disorders or diseases classified elsewhere

6.6

6.3

IGY02, ,

SPAT

2.9

6.3

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

3.6

6.3

RS221, ,

NOMESCO Finland

2.6

6.3

131

F06.8

ICD-10 Finland

Other specified mental disorders due to brain damage and dysfunction and to physical disease

11.0

6.3

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

11.0

6.3

SPAT1104

SPAT

Monitoring of emergency patient

1.7

6.3

117

714

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.5

6.3

174

1168

FXF00

NOMESCO Finland

Decannulation after ECHLA or ECLA

18.1

6.3

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

2.8

6.3

103

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

359

368

11.27

319.32

1.4

1.3

3.68

3.72

mmol/l

0.24

341

346

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

387

406

11.14

307.65

1.5

1.3

437.83

502.84

mg/l

0.81

376

380

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

334

355

10.74

288.83

1.6

1.3

9.72

32.60

e6/l

0.80

274

275

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

334

355

10.74

288.83

1.6

1.4

275.12

1869.49

e6/l

1.09

289

286

(3044290) Cell count panel - Cerebral spinal fluid

297

344

9.69

239.95

1.5

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

255

348

8.07

179.29

6.6

3.0

40.69

34.33

umol/l

2.72

235

318

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1031

4779

3.01

147.21

2.8

2.1

238.41

258.22

u/l

0.17

996

4491

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

143

117

12.92

145.69

1.3

1.2

1.74

1.99

mmol/l

2.31

134

109

(3036481) Cortisol [Moles/volume] in Serum or Plasma

525

1753

3.54

128.48

2.3

2.0

390.56

373.90

nmol/l

0.52

494

1611

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

138

130

11.19

128.24

1.8

1.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

147

161

9.65

122.66

1.2

1.1

44.64

40.19

mg/l

0.16

128

129

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

144

157

9.69

120.54

1.2

1.0

288.97

256.72

mg/l

0.18

127

132

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

158

195

8.60

120.09

1.1

1.0

—

(3016018) Differential panel - Cerebral spinal fluid

142

166

9.02

112.63

1.3

1.4

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

155

206

7.97

110.69

1.1

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

143

177

8.52

108.33

1.1

1.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

135

156

9.10

108.01

1.2

1.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

122

133

9.60

101.99

1.6

1.5

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

639

2743

2.80

98.86

4.7

3.7

0.82

mmol/l

0.10

600

2586

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

12.94

98.70

1.5

1.1

57.22

72.67

—

(3023410) Appearance of Cerebral spinal fluid

134

178

7.91

95.60

1.6

1.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

428

1516

3.21

93.06

9.4

8.2

8.68

9.34

mmol/l

1.18

409

1451

(3005719) IgG [Mass/volume] in Serum or Plasma

401

1387

3.26

90.56

2.4

2.7

10.83

10.70

g/l

0.20

365

1273

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

105

113

9.67

88.54

1.2

1.0

1.06

1.05

u/l

0.05

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

373

1267

3.30

86.57

2.6

2.3

20.09

24.51

au/ml

0.33

103

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1338

8515

2.27

83.70

10.3

6.6

1.21

mmol/l

3.00

1145

7233

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

348

1157

3.34

83.49

1.4

1.3

40.67

56.90

au/ml

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

556

2460

2.63

79.07

2.6

2.3

29.67

29.92

0.40

540

2371

(3022217) INR in Platelet poor plasma by Coagulation assay

1226

7673

2.20

78.06

15.2

13.7

1.18

1.23

inr

1.37

377

2359

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1228

7695

2.20

77.89

10.6

6.0

1.21

mmol/l

2.18

1159

7050

(3013826) Glucose [Moles/volume] in Serum or Plasma

1540

10600

2.23

76.54

8.1

4.6

6.65

6.60

mmol/l

0.34

1463

9786

(3003458) Phosphate [Moles/volume] in Serum or Plasma

507

2234

2.60

72.06

8.2

6.2

1.08

1.05

mmol/l

1.07

487

2077

(3024561) Albumin [Mass/volume] in Serum or Plasma

1168

7443

2.09

67.88

7.0

4.8

35.12

35.96

g/l

4.72

1091

6939

(3003396) Base excess in Arterial blood by calculation

424

1824

2.60

62.59

11.8

8.0

1.02

1.07

mmol/l

0.09

328

1415

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

422

1827

2.58

61.40

12.0

8.0

5.01

5.10

kpa

0.93

404

1738

(3027801) Oxygen [Partial pressure] in Arterial blood

422

1827

2.58

61.40

12.0

8.0

13.33

12.35

kpa

2.47

403

1741

(3016502) Oxygen saturation in Arterial blood

388

1616

2.67

61.06

12.6

8.6

96.07

95.51

0.73

375

1560

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

10.92

60.27

1.3

1.0

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

998

6321

1.98

55.78

4.1

3.3

49.59

58.19

ng/l

0.33

628

3905

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

913

5610

2.00

55.65

3.6

2.5

60.85

58.18

u/l

0.35

864

5206

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1328

9282

1.95

55.31

8.5

5.9

12.41

11.71

umol/l

0.48

1276

8773

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

102

7.66

53.58

1.2

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

266

973

2.95

53.25

14.5

7.6

24.09

24.39

mmol/l

0.55

255

920

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

8.03

52.91

1.2

1.1

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

347

1481

2.57

51.44

13.7

8.9

122.50

123.28

g/l

0.27

337

1435

(3021447) Carbon dioxide [Partial pressure] in Venous blood

362

1593

2.49

50.24

5.9

4.2

5.65

5.85

kpa

3.53

351

1547

(3019060) Gas panel - Arterial blood

274

1052

2.81

50.05

9.6

5.3

—

(3002032) Base excess in Venous blood by calculation

360

1588

2.49

49.67

6.0

4.2

1.33

1.87

mmol/l

1.79

277

1309

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

158

439

3.78

49.24

1.4

1.3

289.26

248.60

u/ml

0.87

109

274

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

153

425

3.77

47.68

1.6

1.5

—

(3037522) Nuclear Ab [Titer] in Serum

503

2606

2.17

47.48

1.5

1.3

390.98

500.91

titre

1.11

102

528

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

156

464

3.52

43.88

1.4

1.3

—

(3020891) Body temperature

184

614

3.16

43.02

8.9

4.9

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

140

397

3.68

42.30

1.6

1.5

97.34

112.68

u/ml

0.62

(3019309) Folate [Moles/volume] in Red Blood Cells

544

3021

2.03

42.16

1.8

1.7

1226.98

1165.12

nmol/l

0.81

441

2299

(1616796) Gas panel - Central venous blood

143

415

3.60

41.74

3.7

3.6

—

(3023368) Bacteria identified in Blood by Culture

745

4630

1.88

41.27

5.1

4.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

206

757

2.88

40.61

1.7

2.0

39.29

39.32

u/l

0.01

186

689

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

923

6192

1.79

39.44

4.9

3.1

49.54

32.26

u/l

0.86

879

5888

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

7.87

39.18

1.7

1.4

—

(3018418) pH of Serum or Plasma

774

4982

1.81

37.61

5.1

3.8

7.39

7.40

0.96

184

970

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

116

5.91

37.15

1.1

0.25

5.80

nmol/l

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

109

284

3.97

37.14

5.0

5.6

378.60

371.66

umol/l

0.20

251

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

602

3620

1.88

36.21

1.7

447.33

29660329.93

pmol/l

3.08

517

3058

(3015377) Calcium [Moles/volume] in Serum or Plasma

867

5824

1.76

36.10

3.4

3.2

2.33

2.35

mmol/l

2.82

780

5181

(3008295) Osmolality of Serum or Plasma

182

4.69

35.36

1.4

1.6

284.26

281.98

mosm/kgh2o

0.40

138

(3014111) Lactate [Moles/volume] in Serum or Plasma

309

1471

2.26

35.22

10.0

7.5

1.53

1.36

mmol/l

1.39

294

1432

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

12.23

35.05

1.1

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

222

4.27

34.75

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

199

779

2.69

34.68

1.4

1.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

251

1099

2.43

34.66

1.9

1.8

1.27

1.41

g/l

0.67

234

1006

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

254

1140

2.37

33.14

11.6

7.8

23.82

24.69

mmol/l

3.29

248

1133

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

322

1596

2.17

33.13

3.6

2.4

0.20

0.22

g/l

3.07

299

1484

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

262

1196

2.33

32.88

3.3

4.54

4.58

pmol/l

0.33

231

1067

(3000991) Gas panel - Venous blood

301

1460

2.21

32.67

12.6

8.9

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1720

14139

1.74

32.50

10.0

7.0

80.51

77.18

u/l

1.87

1646

13324

(3004119) Hemoglobin [Mass/volume] in Venous blood

224

963

2.46

32.12

4.8

3.5

129.58

129.32

g/l

0.05

215

940

(3015171) Extractable nuclear Ab [Units/volume] in Serum

186

733

2.66

31.95

1.3

1.2

0.47

1.08

u/ml

0.68

(3006315) Basophils [#/volume] in Blood

1263

9604

1.65

31.84

7.2

5.8

0.04

e9/l

0.35

1159

8349

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

7.42

31.84

1.2

1.1

2364.11

368.79

ng/l

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1043

7559

1.66

31.70

2.9

2.2

72.07

74.76

nmol/l

2.03

964

6889

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

656

4199

1.77

31.48

2.2

1.8

1.36

1.08

mg/l

0.97

486

3135

(3001604) Monocytes [#/volume] in Blood

1260

9594

1.65

31.45

7.2

5.8

0.56

0.57

e9/l

0.36

1159

8344

(3004789) Transferrin [Mass/volume] in Serum or Plasma

444

2525

1.93

31.16

3.4

2.4

2.36

2.35

g/l

0.10

411

2327

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

256

1184

2.30

31.10

6.6

4.0

5.08

5.15

kpa

0.53

247

1139

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

301

1488

2.17

31.08

1.3

1.2

78.89

149.58

iu/ml

4.14

117

586

(40760892) CBC W Ordered Manual Differential panel - Blood

1200

9054

1.64

30.83

7.8

6.3

—

(3016244) Insulin [Units/volume] in Serum or Plasma

155

4.69

30.42

1.9

3.5

21.96

25.64

mu/l

0.52

150

(3019198) Lymphocytes [#/volume] in Blood

1288

9924

1.63

30.15

7.2

5.8

1.86

1.97

e9/l

2.14

1195

8864

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

246

1136

2.30

29.96

6.7

4.0

1.63

1.66

mmol/l

0.03

164

837

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

415

2337

1.94

29.89

3.5

2.5

24.23

23.66

0.34

346

2017

(3024354) Oxygen [Partial pressure] in Venous blood

275

1333

2.20

29.78

5.8

3.5

4.96

4.68

kpa

1.30

263

1294

(3009343) pH of Capillary blood

251

1172

2.27

29.78

6.7

4.1

7.41

7.40

0.11

140

(3022948) Iron [Moles/volume] in Serum or Plasma

467

2756

1.86

29.05

3.5

2.5

13.56

13.74

umol/l

0.20

433

2563

(3015235) Bicarbonate [Moles/volume] in Capillary blood

130

445

3.03

29.01

3.7

3.3

23.36

24.76

mmol/l

2.50

125

438

(3013115) Eosinophils [#/volume] in Blood

1283

9934

1.62

28.97

7.4

6.1

0.18

0.19

e9/l

0.64

1185

8791

(3026008) Bacteria identified in Urine by Culture

773

5291

1.68

28.56

3.6

2.7

—

(3010421) pH of Blood

139

499

2.89

28.49

4.6

4.1

7.41

7.42

0.63

119

443

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

464

2763

1.84

27.94

2.1

1.8

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

954

6923

1.62

27.77

2.3

1.9

96.29

95.47

pmol/l

0.22

569

3775

(3020630) Protein [Mass/volume] in Serum or Plasma

259

1267

2.17

27.33

2.3

2.6

66.49

66.91

g/l

0.39

241

1168

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

260

1274

2.17

27.32

2.7

2.3

12.89

7.17

ug/l

1.43

234

1128

(3013650) Neutrophils [#/volume] in Blood by Automated count

1389

11050

1.60

27.32

9.9

8.7

4.10

4.07

e9/l

0.24

1282

9645

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

148

562

2.74

27.30

2.6

2.4

635.84

490.06

ug/l

0.30

136

526

(3033658) Prothrombin time (PT) actual/Normal

675

4511

1.69

27.04

7.0

3.9

88.85

90.71

1.01

656

4395

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

6.48

26.92

1.1

1.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

385

2198

1.89

26.36

2.0

1.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

7.65

26.35

1.2

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

7.65

26.35

1.2

1.1

—

(3012501) Base excess in Blood by calculation

120

416

2.98

26.19

4.7

4.2

2.10

2.39

mmol/l

0.52

266

(3013290) Carbon dioxide [Partial pressure] in Blood

120

417

2.97

26.08

4.7

4.2

4.85

5.02

kpa

1.47

114

411

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

342

1893

1.94

25.67

3.7

4.1

263.17

250.29

u/l

0.36

319

1796

(3027315) Oxygen [Partial pressure] in Blood

119

417

2.95

25.48

4.8

4.3

9.30

8.57

kpa

4.48

113

411

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

893

6502

1.59

24.92

4.0

3.1

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

146

579

2.62

24.72

1.6

1.7

1.12

1.18

g/l

1.47

141

550

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

142

557

2.65

24.57

1.6

1.7

0.22

0.24

g/l

1.99

137

530

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

690

4758

1.63

23.95

2.8

2.2

2.97

2.90

mg/l

0.32

618

4057

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

147

598

2.55

23.62

1.6

1.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

586

3891

1.67

23.56

1.7

1.5

20.26

20.27

nmol/l

0.00

521

3373

(3036489) Thrombin time

163

699

2.43

23.40

2.7

2.4

21.42

21.32

0.09

142

612

(3020191) Ethanol [Moles/volume] in Serum or Plasma

155

4.15

23.24

1.6

1.5

0.76

1.30

promille

2.22

122

(3047181) Lactate [Moles/volume] in Blood

131

509

2.66

23.10

10.9

7.1

1.50

1.34

mmol/l

0.50

117

434

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.81

22.52

1.2

1.1

—

(3022096) Basophils/100 leukocytes in Blood

1124

8754

1.53

22.52

7.5

6.0

0.62

0.66

1.83

1078

8194

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

122

466

2.70

22.25

1.6

2.2

11.06

10.86

mg/l

0.10

116

431

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

6.69

22.13

1.2

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

4.93

22.04

1.6

1.5

5.67

8.29

u/l

0.66

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

631

4333

1.62

21.96

3.4

3.0

1452.39

1452.31

ng/l

0.00

535

3632

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

139

572

2.52

21.80

3.6

2.9

3.15

3.59

g/l

3.23

130

539

(3019069) Monocytes/100 leukocytes in Blood

1158

9119

1.51

21.76

8.1

6.2

8.36

8.40

0.15

1113

8573

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

494

3196

1.68

21.72

4.5

3.4

1202.61

473.27

ng/l

0.86

329

2268

(3026782) Osmolality of Urine

547

3639

1.65

21.58

3.5

2.7

524.50

554.49

mosm/kgh2o

2.47

478

3115

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

235

1219

2.03

21.09

1.9

1.6

—

(3006504) Eosinophils/100 leukocytes in Blood

1148

9062

1.50

21.08

7.7

5.9

2.71

2.81

0.88

1101

8502

(3007164) IgA [Mass/volume] in Serum or Plasma

594

4056

1.61

21.02

1.7

1.5

2.45

2.31

g/l

0.79

408

2518

(3013247) Albumin in CSF/Albumin in Serum or Plasma

7.40

20.79

1.0

14.06

6.37

mg/g

0.56

(3042733) HLA Ab [Presence] in Serum

5.75

20.71

3.6

4.3

—

(3002030) Lymphocytes/100 leukocytes in Blood

1183

9431

1.49

20.49

7.7

6.0

27.45

28.59

3.28

1136

8897

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

6.55

20.48

1.2

1.1

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1627

13850

1.53

20.44

5.0

3.8

11.13

10.90

mm/h

0.27

1535

12834

(3031040) Bacteria [#/volume] in Urine by Automated count

1501

12564

1.51

20.43

5.6

4.0

808.73

1707.78

e6/l

0.58

158

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

136

573

2.45

20.29

1.6

80.00

173.33

titre

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

187

903

2.16

20.27

6.7

4.6

23.30

23.99

mmol/l

2.08

182

888

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

176

842

2.18

19.53

15.1

11.7

—

(3039000) Anion gap in Blood

341

2.86

19.51

13.4

9.0

11.68

11.65

mmol/l

0.02

301

(3018572) Chloride [Moles/volume] in Blood

342

2.85

19.40

13.4

9.0

105.71

105.57

mmol/l

0.07

302

(3018010) Neutrophils/100 leukocytes in Blood

1159

9287

1.47

19.05

7.7

5.8

57.73

56.81

2.02

1112

8746

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

135

586

2.38

18.87

1.4

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

141

624

2.34

18.86

10.6

6.2

1.20

0.90

0.75

130

577

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

411

2627

1.68

18.66

2.0

1.8

1.52

1.43

1.87

366

2333

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

142

634

2.32

18.61

10.3

6.1

1.67

1.64

0.10

130

586

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

122

513

2.45

18.29

4.2

3.6

0.30

0.33

u/ml

0.59

286

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

332

2014

1.75

18.21

7.9

6.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

5.45

18.08

1.1

1.0

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

316

1896

1.77

18.00

2.1

1.7

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

148

3.78

17.99

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

228

3.18

17.72

1.4

1.3

0.11

0.43

nmol/l

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

4.62

17.52

2.7

2.4

58.88

45.43

umol/l

1.85

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1141

9212

1.45

17.47

4.3

2.8

108.40

109.20

ug/l

0.05

1071

8599

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

205

3.28

17.40

1.4

1.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

312

1886

1.75

17.28

2.1

1.7

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

319

2.79

17.20

1.6

1.5

—

(3048689) Calprotectin [Mass/mass] in Stool

393

2537

1.65

17.06

2.1

2.5

120.53

120.45

ug/g

0.00

294

2018

(3029937) Albumin [Presence] in Urine by Test strip

688

5051

1.50

17.05

4.9

3.6

0.00

estimate

1.49

260

1809

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

172

862

2.07

16.91

13.3

10.3

24.09

24.38

mmol/l

0.56

165

838

(4062490) Immunoglobulin typing, IgG

174

3.45

16.88

2.0

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

641

4648

1.51

16.82

1.4

1.3

1.56

1.63

u/ml

0.04

199

1211

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

127

565

2.32

16.80

3.1

2.7

173.70

176.83

0.16

122

540

(3033799) Differential panel - Peritoneal fluid

5.83

16.65

3.5

2.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

153

738

2.15

16.63

1.5

1.4

9.64

9.06

u/l

0.20

129

598

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1708

14963

1.47

16.40

5.0

3.9

14.64

14.60

pmol/l

0.26

1604

13731

(3017143) Hepatitis C virus Ab [Presence] in Serum

409

2693

1.62

16.36

1.7

1.6

—

(3002582) Erythrocytes [#/volume] in Urine

736

5517

1.48

16.32

4.0

3.1

41.10

92.43

e6/l

1.91

610

4243

(3044007) Cell count panel - Peritoneal fluid

5.86

16.19

4.2

2.0

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

129

590

2.25

15.99

1.8

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

129

3.78

15.76

1.9

2.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

4.78

15.65

1.5

1.2

143.42

173.27

mmol/24h

1.39

(3000850) Epithelial cells [#/volume] in Urine

543

3857

1.52

15.53

3.2

2.5

6.08

6.34

e6/l

0.17

496

3458

(3028192) IgG subclass 2 [Mass/volume] in Serum

174

3.33

15.48

1.8

1.3

2.91

2.84

g/l

0.11

124

(3023487) Leukocytes [#/volume] in Peritoneal fluid

4.98

15.47

3.6

2.3

268.82

898.98

e6/l

2.08

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

205

3.13

15.42

1.4

1.3

—

nmol/l

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

137

653

2.16

15.35

3.0

2.0

2.67

1.88

ug/l

0.30

123

579

(3007566) Smooth muscle Ab [Titer] in Serum

115

513

2.30

15.13

1.3

72.73

88.48

titre

0.31

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

6.10

15.12

1.0

1.1

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1534

13265

1.42

15.05

5.3

4.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

222

1266

1.83

14.91

2.5

2.3

4703.97

5206.46

u/l

0.10

520

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

328

2091

1.66

14.83

5.3

2.8

11.47

8.12

umol/l

0.84

273

1799

(3027135) IgG subclass 1 [Mass/volume] in Serum

174

3.27

14.79

1.8

1.3

6.54

6.77

g/l

0.14

126

(3024139) IgG subclass 3 [Mass/volume] in Serum

174

3.27

14.79

1.8

1.3

0.43

0.39

g/l

0.30

123

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

213

1207

1.84

14.60

5.1

4.2

96.05

87.30

ng/l

0.56

186

1074

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

336

2.59

14.55

1.4

21.58

21.22

u/l

0.03

285

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

918

7291

1.42

14.53

4.6

3.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

236

1383

1.78

14.47

5.1

3.5

1.22

mmol/l

0.85

214

1182

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

386

2.47

14.38

7.5

6.2

838.94

770.43

iu/ml

0.04

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

104

455

2.34

14.32

1.4

1.3

—

(3003181) Sodium [Moles/volume] in Urine

248

2.83

14.20

2.4

1.4

75.91

68.80

mmol/l

0.44

202

(44816559) Phosphatidylethanol [Mass/volume] in Blood

411

2.39

13.89

1.6

1.3

—

(3035350) Ketones [Presence] in Urine by Test strip

1137

9419

1.39

13.84

4.4

3.3

0.00

estimate

1.34

277

1945

(40767503) Oxygen content in Capillary blood by calculation

378

2.43

13.59

3.4

2.5

17.46

16.32

1.82

196

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

4.35

13.58

2.0

2.8

66.33

137.30

umol/l

1.28

(3019150) Specific gravity of Urine by Refractometry

556

4066

1.48

13.57

4.8

3.6

1.02

kg/l

0.19

594

(3024980) IgG subclass 4 [Mass/volume] in Serum

289

2.65

13.53

1.8

1.7

0.76

0.79

g/l

0.08

225

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.90

13.52

1.0

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

189

1060

1.85

13.38

1.6

1.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

4.60

13.30

3.4

2.9

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

114

536

2.18

13.25

7.6

5.0

1.61

1.45

mg/l

1.04

106

496

(3027945) Reticulocytes/100 erythrocytes in Blood

298

1906

1.64

13.24

2.9

2.7

1.80

1.75

0.31

250

1719

(3021901) Oxygen saturation in Capillary blood

328

2.52

13.22

3.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

272

2.66

12.97

2.4

2.5

—

(3013512) EKG study

634

4789

1.44

12.97

4.3

3.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

119

3.57

12.82

1.3

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

3.96

12.72

1.2

1.4

129.28

142.65

nmol/l

0.94

(3044640) Blood type and Crossmatch panel - Blood

760

5956

1.40

12.55

2.9

2.3

—

(3009261) Glucose [Presence] in Urine by Test strip

1132

9469

1.37

12.51

4.4

3.3

0.00

estimate

0.80

261

1809

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

4.25

12.45

1.0

1366.64

317.55

ng/l

0.49

(3021601) Nitrite [Presence] in Urine by Test strip

1121

9382

1.36

12.26

5.6

4.5

0.00

estimate

0.50

268

1881

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

251

2.67

12.25

1.2

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1084

9028

1.36

12.22

3.1

2.5

—

(3030467) Casts [#/volume] in Urine by Automated count

656

5032

1.42

12.20

3.7

3.0

0.43

e6/l

0.01

538

3817

(3042936) Bacteria identified in Isolate by Culture

370

2537

1.54

12.19

2.5

2.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

109

3.62

12.16

1.7

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

4.78

12.13

4.0

1.8

2158.94

30064.79

e6/l

0.53

(3000570) Elastase.pancreatic [Mass/mass] in Stool

101

474

2.18

11.82

1.4

317.09

299.80

ug/g

0.32

256

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

429

3054

1.49

11.81

2.9

2.43

2.44

mmol/l

0.64

362

2660

(3023520) Reticulocytes [#/volume] in Blood

224

1370

1.70

11.78

2.5

2.7

70.72

70.79

e9/l

0.01

173

1039

(3018095) Leukocytes [#/volume] in Urine

825

6612

1.37

11.73

4.7

3.5

67.28

97.71

e6/l

0.69

636

4564

(3030981) Hyaline casts [#/volume] in Urine by Automated count

160

889

1.86

11.68

3.4

2.8

0.31

0.23

e6/l

0.24

155

859

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

4.12

11.59

1.0

33.35

45.24

ng/l

0.78

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

4.12

11.59

1.0

776.46

680.22

ng/l

0.45

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

210

1268

1.72

11.57

3.3

2.8

182.04

194.90

ng/l

0.19

186

1150

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

160

3.04

11.35

1.1

276.60

291.33

mg/l

0.65

144

(3021387) Prolactin [Units/volume] in Serum or Plasma

176

1017

1.79

11.31

1.7

1.6

335.11

297.85

mu/l

0.63

159

920

(3024932) HLA-DR beta [Type]

4.24

11.27

1.1

—

(3022313) Gas panel - Capillary blood

156

870

1.85

11.26

8.2

4.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

329

2.38

11.24

1.2

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

3.68

11.23

1.1

1608.77

1568.33

miu/ml

0.06

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

194

2.82

11.19

1.6

1.7

—

(3015736) pH of Urine

928

7619

1.35

11.17

3.9

3.0

6.04

5.88

0.62

667

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

102

493

2.12

11.09

2.2

1.6

—

(36304419) Bacteria [Presence] in Urine

641

4966

1.39

11.08

3.7

2.9

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

168

2.96

11.05

1.3

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

5.75

11.00

1.0

1.1

—

(3024471) HLA-A [Type]

4.12

10.87

1.1

1.0

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

3.75

10.85

1.3

1.6

3.68

1.94

nmol/l

0.32

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

107

532

2.06

10.81

2.3

2.8

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

193

1162

1.72

10.75

1.6

1.4

18.09

23.34

iu/l

1.88

168

974

(3025941) Bacteria identified in Stool by Culture

190

1139

1.72

10.75

1.3

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1502

13286

1.34

10.72

5.0

3.0

53.78

43.73

u/l

4.09

1418

12520

(3002331) Protein [Mass/volume] in Peritoneal fluid

5.59

10.70

1.5

16.55

25.62

g/l

1.06

(46235355) HIV 1 and 2 tests - Meaningful Use set

646

5036

1.38

10.69

2.0

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2085

19473

1.49

10.62

25.6

13.7

139.37

139.60

mmol/l

3.70

2059

18930

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

390

2.22

10.54

2.9

3.8

58.51

57.15

0.45

390

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

378

2.21

10.07

1.5

1.4

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

378

2.21

10.07

2.6

3.5

4.04

4.14

e9/l

0.14

378

(3004588) Protein electrophoresis panel - Serum or Plasma

172

1022

1.73

10.05

2.1

2.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

418

2.15

10.03

1.4

1.5

0.32

0.42

nmol/l

0.91

347

(3005322) IgE [Units/volume] in Serum or Plasma

212

1334

1.65

10.00

1.4

1.3

329.41

208.08

u/ml

0.42

190

1238

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

309

2.34

9.99

1.3

2.03

5.22

u/ml

1.91

113

(3023103) Potassium [Moles/volume] in Serum or Plasma

2086

19535

1.47

9.97

25.2

13.8

3.94

3.95

mmol/l

0.75

2054

18957

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

270

1807

1.56

9.84

4.3

3.3

—

(40761535) Cells panel - Urine sediment

221

1415

1.62

9.72

4.3

3.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

580

4503

1.38

9.71

2.9

2.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

384

2.17

9.70

2.7

2.3

132.32

130.91

g/l

0.18

298

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

278

2.37

9.52

1.1

1.58

1.49

g/l

0.89

253

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

161

2.83

9.44

1.2

1.3

71.00

253.23

titre

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

161

2.83

9.44

1.2

1.3

—

217.14

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

104

540

1.97

9.35

1.5

2.3

2.73

2.96

g/l

1.27

493

(3011412) CD3 cells [#/volume] in Blood

180

2.70

9.23

2.4

2.6

1.39

1.24

e9/l

0.45

164

(40768797) Stomach Pathology biopsy report

346

2473

1.47

9.19

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

10.06

9.01

1.0

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

135

773

1.79

8.98

9.2

4.3

24.38

24.75

mmol/l

0.63

129

732

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

299

2.28

8.93

1.4

1.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

107

572

1.91

8.85

1.6

2.3

6.81

7.30

g/l

1.93

525

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

107

572

1.91

8.85

1.6

2.3

—

(40758558) Short blood count panel - Blood

600

4746

1.35

8.80

7.9

6.6

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

106

572

1.89

8.53

1.6

2.3

3.51

3.64

g/l

0.41

524

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

3.53

8.52

1.2

—

(3037121) Protein [Mass/volume] in Urine

117

652

1.83

8.52

3.1

3.4

0.37

0.28

g/l

0.61

274

(3019225) pH of Specimen

243

1641

1.53

8.49

4.9

4.1

—

(3044889) 12 lead EKG panel

1408

12551

1.29

8.42

4.1

3.4

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

4.31

8.40

1.7

1.4

10.77

13.83

g/l

0.68

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

4.66

8.35

1.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

323

2.17

8.22

1.3

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

3.40

8.07

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

274

2.26

8.04

1.2

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

229

3301

0.66

8.03

2.8

3.0

0.63

0.76

ug/l

2.05

150

2135

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

300

2.20

8.03

4.0

3.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

10.05

8.02

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

307

2.18

8.00

1.3

3.03

4.63

u/ml

0.90

142

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

294

2.21

8.00

1.2

1.1

111.68

116.48

0.60

272

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

4.14

7.99

2.0

3.1

29.72

29.16

umol/l

0.07

(3003327) Ova and parasites identified in Stool by Light microscopy

120

690

1.78

7.90

2.0

1.7

—

(4200892) Spirometry reversibility

186

1202

1.59

7.89

1.5

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

655

5324

1.31

7.83

3.8

2.9

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

3.89

7.70

1.2

1.6

81.17

101.15

nmol/24h

0.70

(3017181) Myelocytes/100 leukocytes in Blood

227

1543

1.52

7.70

4.4

4.1

0.90

0.95

0.15

512

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

7.44

7.67

1.1

1.0

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

537

4258

1.34

7.61

4.3

3.3

—

(3028707) Methadone [Presence] in Urine by Screen method

497

1.88

7.42

2.4

2.9

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

7.66

7.38

1.1

1.2

—

(3021589) Normoblasts [#/volume] in Blood

999

8624

1.27

7.37

12.9

8.9

0.00

e9/l

0.35

878

7009

(36660697) Celiac disease serology panel - Serum

236

1633

1.49

7.35

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

539

1.83

7.18

1.5

2.4

10.56

10.47

g/l

0.06

490

(3025159) Blasts/100 leukocytes in Blood

207

1405

1.52

7.08

4.3

4.2

0.06

0.56

0.95

375

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

498

1.86

7.07

1.5

2.4

0.63

1.00

g/l

0.62

444

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

112

2.88

7.06

1.2

1.1

1.09

1.05

ratio

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

5.62

7.06

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

449

1.90

7.02

1.4

2.2

0.00

0.02

g/l

0.72

416

(3023511) Choriogonadotropin [Units/volume] in Urine

115

678

1.73

6.98

1.5

1.3

—

(21494755) Public health laboratory ask at order entry panel

153

2334

0.63

6.97

1.3

—

(3024869) Neuronal Ab [Presence] in Serum

6.33

6.93

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

419

3248

1.35

6.85

1.3

127.79

27.78

iu/ml

0.52

103

1026

(3036180) Methadone [Presence] in Urine

109

2.87

6.79

1.7

1.9

—

(3021440) Promyelocytes/100 leukocytes in Blood

214

1476

1.49

6.78

4.3

4.2

0.12

0.13

0.07

443

(3000963) Hemoglobin [Mass/volume] in Blood

2133

22128

0.71

6.77

31.5

18.3

133.69

135.81

g/l

8.53

2110

21831

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

4.27

6.75

6.3

6.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

3.09

6.74

37.8

26.2

120.15

129.27

ug/l

0.30

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.90

6.71

1.3

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

7.18

6.70

1.1

1.3

—

(3002179) Metamyelocytes/100 leukocytes in Blood

206

1415

1.50

6.66

3.8

3.9

0.64

0.69

0.15

446

(3010813) Leukocytes [#/volume] in Blood

2133

22120

0.71

6.63

31.3

18.2

6.98

6.77

e9/l

3.40

2089

21525

(3026361) Erythrocytes [#/volume] in Blood

2133

22119

0.71

6.62

31.3

18.2

4.45

4.52

e12/l

8.97

2087

21526

(3035941) MCH [Entitic mass]

2133

22117

0.71

6.58

31.1

18.1

30.27

30.18

1.30

2113

21820

(3024731) MCV [Entitic volume]

2133

22116

0.71

6.56

31.2

18.1

90.66

90.46

1.20

2114

21821

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

110

654

1.71

6.50

2.1

1.8

—

(40768441) Liver Pathology biopsy report

135

2.62

6.46

2.2

1.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

147

2.54

6.44

1.5

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

3.31

6.41

1.5

4.1

8177.28

82.74

mg/l

0.48

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

303

2.04

6.31

1.7

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

303

2.04

6.31

1.7

1.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

199

1374

1.49

6.28

2.7

2.6

67.33

69.99

ml/min/173m2

0.43

509

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

3.26

6.28

1.0

1.1

87.88

92.27

0.43

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

155

2.47

6.27

1.0

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

155

2.47

6.27

1.0

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

155

2.47

6.27

1.0

1.1

—

(3007461) Platelets [#/volume] in Blood

2133

22097

0.72

6.24

31.4

18.2

252.72

253.41

e9/l

0.17

2095

21553

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

346

1.96

6.23

1.6

1.5

—

(3009508) Creatinine [Moles/volume] in Urine

649

5404

1.27

6.22

3.5

3.3

7.59

7.96

mmol/l

1.01

566

4633

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

118

724

1.66

6.22

2.3

1.9

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

306

2.02

6.16

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

3.41

6.14

2.1

2.3

307.69

221.39

e6/l

0.26

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

157

2.44

6.11

1.0

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

157

2.44

6.11

1.0

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

456

1.83

6.10

1.3

2.2

37.01

37.90

g/l

0.40

410

(40761536) Microorganisms panel - Urine sediment

241

1737

1.43

6.09

4.8

3.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

3.10

6.04

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

158

2.43

6.04

1.0

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

2133

22084

0.73

6.02

31.8

18.3

39.64

40.51

3.03

2000

20839

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

276

2.05

5.94

1.2

1.8

—

1697.78

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

992

0.49

5.93

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

230

2.15

5.89

1.4

1.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

339

1.94

5.89

1.0

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

504

4095

1.29

5.83

1.8

1.7

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

443

1.81

5.74

1.8

1.7

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

118

740

1.62

5.73

2.1

1.9

1.23

1.45

g/l

1.91

101

647

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

214

2.17

5.67

1.4

1.6

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

214

2.17

5.67

1.4

1.6

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

365

2848

1.33

5.66

3.5

2.8

3.86

2.57

e6/l

1.12

219

1535

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

7.53

5.63

1.0

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

332

1.92

5.56

1.0

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

8.49

5.55

1.1

1.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

8.49

5.55

1.2

1.3

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

10.04

5.53

1.2

1.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

147

980

1.53

5.51

1.8

1.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

137

2029

0.66

5.44

1.7

1.6

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1887

17809

1.26

5.42

5.9

4.5

1.83

2.00

mu/l

1.02

1781

16508

(3019977) pH of Arterial blood

2.83

5.41

2.2

3.1

7.44

7.42

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

772

0.46

5.36

1.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

388

3079

1.31

5.33

1.3

1.2

5.01

11.02

u/ml

1.33

151

1236

(3026389) Candida sp identified in Specimen by Organism specific culture

240

2.06

5.32

1.6

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2053

19593

1.30

5.31

22.3

12.4

20.80

23.03

mg/l

2.65

1750

15266

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

137

2.43

5.30

2.7

2.8

0.22

0.21

e9/l

0.07

122

(3047352) Trisomy 18 risk [Likelihood] in Fetus

754

0.46

5.28

1.4

1.5

—

(3011288) Drugs identified in Urine by Screen method

122

788

1.58

5.27

2.7

2.9

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

5.02

5.25

3.3

3.7

48.87

45.69

umol/l

0.26

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

585

1.67

5.24

1.1

3.37

3.50

u/ml

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

332

1.89

5.24

1.2

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

434

1.78

5.23

1.9

1.7

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

132

2.44

5.21

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

139

2.39

5.14

2.7

2.8

627.42

555.52

e6/l

0.30

122

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

423

1.77

5.09

1.4

2.3

0.00

g/l

-0.00

394

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

498

1.71

5.09

1.3

1.2

2.56

6.66

u/ml

1.06

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

5.21

5.08

1.4

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

5.21

5.08

1.4

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

5.68

5.06

1.7

2.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

308

1.90

5.04

1.1

—

(3023419) Bacteria identified in Sputum by Culture

253

2.00

4.99

2.9

2.8

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

2.82

4.98

1.7

1.6

—

881935.71

iu/ml

—

(3005033) Fetal Nuchal fold Thickness US

750

0.47

4.97

1.4

1.5

—

(3000494) Fungus identified in Specimen by Culture

284

2177

1.34

4.96

1.7

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

235

1749

1.38

4.95

1.5

—

(3026493) Urate [Moles/volume] in Serum or Plasma

557

4664

1.25

4.95

3.0

2.6

4789.80

4972.45

umol/l

0.03

497

4121

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

6.90

4.95

1.1

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

5.02

4.94

4.5

3.0

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

427

1.76

4.94

1.4

2.3

0.00

g/l

-0.00

395

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

220

2.07

4.93

1.8

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

174

2.20

4.91

1.7

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

536

1.67

4.84

1.3

1.2

9.73

41.48

u/ml

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

3.00

4.83

1.0

1.4

81.64

92.29

0.70

(1761868) Lipid panel - Serum or Plasma

621

7233

0.81

4.80

2.7

2.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

492

1.69

4.77

1.3

1.2

40.01

2.48

u/ml

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

232

1734

1.37

4.77

3.5

2.4

30.67

64.49

u/l

0.66

199

1476

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

3.12

4.64

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

226

2.01

4.61

2.4

2.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

134

2.33

4.59

1.0

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

373

3003

1.29

4.57

3.1

2.7

1.32

1.23

e6/l

0.11

228

1688

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

909

0.54

4.57

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

319

1.84

4.56

1.6

1.5

—

(3024928) Oxygen saturation in Venous blood

363

1.78

4.55

4.1

3.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.87

4.49

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

181

2.12

4.48

2.3

4.8

103.75

86.16

u/ml

0.13

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

264

1.91

4.46

1.3

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

195

2.07

4.45

4.0

6.5

9.76

6.93

mmol/l

0.41

163

(4034850) Laboratory test

580

1.61

4.45

14.4

8.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

913

0.55

4.43

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

216

2.01

4.42

1.8

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

912

0.55

4.41

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

912

0.55

4.41

1.4

—

(3028433) Virus identified in Specimen by Culture

3.01

4.39

1.1

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

124

840

1.50

4.37

2.3

—

(3038515) Glucose [Moles/volume] in Venous blood

309

1.83

4.37

4.1

3.1

7.63

7.41

mmol/l

0.19

302

(3025468) Yersinia sp identified in Specimen by Organism specific culture

218

1.99

4.31

1.8

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

218

1.99

4.31

1.8

1.5

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

340

1.78

4.30

1.1

19.81

1434.38

iu/ml

0.54

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

120

1738

0.67

4.29

1.4

1.5

—

(3004616) Nuclear Ab [Presence] in Serum

212

2.00

4.27

1.3

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

219

1.98

4.26

1.8

1.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

276

1.87

4.24

2.6

3.8

1.99

1.29

0.63

252

(3024522) Salmonella sp identified in Specimen by Organism specific culture

220

1.97

4.21

1.8

1.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

3.27

4.18

1.6

1.9

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

110

736

1.52

4.13

1.4

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

4.63

4.05

2.8

2.2

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

143

2.18

3.99

12.0

0.66

0.63

mmol/l

0.26

128

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

6.45

3.98

1.0

—

(4035726) Immunohistochemistry procedure

202

1523

1.36

3.96

1.5

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

196

1472

1.36

3.94

2.6

2.1

11.31

12.16

nmol/l

0.61

168

1324

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

3.14

3.93

1.7

2.7

76.37

79.39

ug/l

0.03

(3017732) Neutrophils [#/volume] in Blood

179

1326

1.38

3.92

2.8

4.25

5.26

e9/l

1.07

146

1135

(1001926) Buprenorphine [Presence] in Urine by Screen method

127

885

1.46

3.92

2.1

—

(3052851) Hemolysis interference index of Serum or Plasma

512

1.60

3.91

3.4

2.9

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

372

4491

0.80

3.90

3.6

4.1

21.82

21.52

0.13

155

2091

(3038071) Oxygen [Partial pressure] in Mixed venous blood

3.80

3.89

6.1

6.0

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

119

2.28

3.87

2.9

40.68

43.50

0.36

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.80

3.87

1.9

2.5

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

7.29

3.86

3.4

4.5

—

(3051611) Lipemic interference index of Serum or Plasma

159

2.09

3.82

3.4

3.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

6.02

3.81

1.2

1.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.85

3.79

1.4

1.5

—

(3020961) Endomysium IgA Ab [Titer] in Serum

144

1035

1.42

3.77

1.1

—

145.52

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

160

2.08

3.77

1.2

73.06

64.25

u/l

0.28

150

(3013336) Amino acids [Identifier] in Serum or Plasma

12.02

3.76

2.0

3.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1781

18642

0.83

3.75

4.4

3.9

1.38

1.45

mmol/l

10.88

1673

17368

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.74

3.75

1.2

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

2.74

3.75

2.3

1.8

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

409

1.66

3.73

1.3

1.2

58.64

36.63

u/ml

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

161

2.06

3.71

3.4

2.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

362

0.36

3.71

1.7

1.6

—

(4281824) Cell count and differential, peritoneal fluid

175

2.01

3.69

1.5

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

182

1.99

3.68

1.9

2.5

1.80

1.86

g/24h

0.03

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

226

1.87

3.60

1.3

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

166

1234

1.37

3.58

1.2

—

(3045424) Erythrocytes [Presence] in Urine

300

1.75

3.56

1.5

1.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

571

4949

1.20

3.51

4.2

3.9

17.66

9.98

mg/mmol

1.60

395

3223

(3022145) Colonoscopy Study observation

247

1953

1.29

3.50

1.3

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

10.02

3.50

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

317

1.72

3.49

2.0

1.8

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

265

1.79

3.48

1.6

1.7

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

568

1.53

3.48

2.3

3.6

56.91

2597.05

u/ml

0.80

475

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1798

18765

0.84

3.44

4.5

3.9

4.54

4.67

mmol/l

6.33

1689

17584

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.56

3.43

1.0

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

380

1.65

3.43

1.6

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

380

1.65

3.43

1.6

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1828

19044

0.84

3.38

4.8

4.3

2.73

2.79

mmol/l

2.42

1711

17715

(3006922) Hepatitis E virus Ab [Presence] in Serum

127

2.14

3.36

1.1

1.0

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

622

1.50

3.35

1.4

1.6

0.42

10.42

iu/ml

0.48

117

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

255

1.78

3.30

1.3

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

3.65

3.29

1.0

—

(3012516) Albumin [Mass/volume] in Urine

544

4726

1.19

3.24

3.5

3.3

783.46

279.43

mg/l

1.09

368

3123

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1394

0.69

3.24

1.4

—

(3016879) Cocaine [Presence] in Urine

141

1039

1.38

3.24

2.1

2.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

123

2.13

3.20

1.6

2.1

3.43

2.25

u/field

0.29

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

6.38

3.18

1.0

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.26

3.13

1.0

1.2

0.61

0.67

umol/24h

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

515

4468

1.19

3.11

1.9

1.6

—

(3037756) Immunofixation for Serum or Plasma

298

1.69

3.10

1.5

1.6

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

414

0.45

3.09

1.3

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

148

1111

1.35

3.04

2.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

285

1.70

3.02

1.4

1.2

42.83

39.00

u/l

0.07

241

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

3.86

2.98

6.3

7.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

212

1.81

2.96

1.1

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

103

732

1.43

2.94

1.7

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

295

1.67

2.94

1.2

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.28

2.93

1.6

1.4

—

(3028300) Cannabinoids [Presence] in Urine

148

1120

1.34

2.90

2.2

2.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

446

1.54

2.89

2.8

3.4

39.20

64.22

mg/l

0.43

359

(3034860) Kappa light chains.free [Mass/volume] in Serum

446

1.54

2.89

2.8

3.4

67.27

63.54

mg/l

0.07

358

(40768800) Prostate Pathology biopsy report

348

0.43

2.89

1.0

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

2.51

2.87

1.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

215

1.78

2.84

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

432

1.54

2.84

2.7

3.4

3.37

1.55

ratio

—

(3027008) Opiates [Presence] in Urine

147

1118

1.34

2.80

2.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.65

2.79

2.0

2.3

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

2.65

2.79

1.1

63.78

46.79

u/ml

0.25

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

493

5620

0.85

2.79

3.8

4.8

1.69

2.80

ug/l

5.10

432

5039

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

152

1163

1.33

2.78

1.1

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

3.92

2.77

1.1

1.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

3.09

2.77

1.4

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

516

1.49

2.76

1.5

2.0

2.35

4.75

iu/l

5.20

192

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

152

1.92

2.75

2.0

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

152

1.92

2.75

2.0

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

152

1.92

2.75

2.0

1.6

—

(40760888) Immunoglobulin light chains.free panel - Serum

333

1.60

2.72

3.2

3.6

—

(40768804) Tissue Pathology biopsy report

826

7513

1.15

2.70

2.2

2.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.60

2.70

2.7

2.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.60

2.70

2.7

2.6

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

6.01

2.70

1.3

3.0

—

(3051651) Icteric interference index of Serum or Plasma

106

2.09

2.63

3.5

—

(3000034) Microalbumin [Mass/volume] in Urine

134

1.95

2.60

3.7

3.6

22.68

40.53

mg/l

0.55

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.06

2.56

7.1

6.3

—

(3027944) Amphetamines [Presence] in Urine

143

1101

1.32

2.53

2.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

192

1538

1.27

2.51

2.7

4.2

11.35

23.79

ug/l

0.92

155

1237

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.17

2.51

1.7

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

375

3223

1.19

2.50

2.2

2.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

399

1.52

2.44

3.5

4.0

—

(3020393) Adenovirus Ag [Presence] in Stool

3.13

2.43

2.5

1.7

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1754

16850

1.15

2.39

6.0

5.0

38.81

38.98

mmol/mol

0.30

1653

15712

(3003338) MCHC [Mass/volume]

1659

17272

0.88

2.39

26.9

15.5

333.20

332.97

g/l

0.45

1651

17129

(3044927) Protein electrophoresis panel - Urine

153

1.84

2.38

1.3

1.2

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

6.26

2.37

2.4

5.3

—

(3036525) Urea [Moles/time] in 24 hour Urine

6.26

2.37

1.4

4.3

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

6.26

2.37

2.4

5.0

—

(3042517) Benzodiazepines panel - Urine

3.64

2.36

3.9

2.6

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

132

1.90

2.36

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

578

1.42

2.33

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

133

1.89

2.31

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

572

1.41

2.28

1.2

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.76

2.27

1.0

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

120

1.93

2.25

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

120

1.93

2.25

1.1

1.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

106

1.99

2.25

1.6

1.5

11.75

6.19

u/l

0.41

(3002621) Streptococcal DNAse B [Units/volume] in Serum

3.90

2.25

1.0

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

2.16

2.24

1.1

26.65

27.00

u/l

0.01

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

209

1.68

2.23

1.8

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.20

2.21

1.6

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.20

2.21

1.6

1.5

—

(3000492) Spirometry study

239

1995

1.22

2.19

1.3

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

158

1.78

2.17

1.2

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

570

1.40

2.15

1.2

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

3.69

2.15

1.1

1.2

—

(40768446) Kidney Pathology biopsy report

2.17

2.14

2.4

1.7

—

(3045414) Leukocytes [Presence] in Urine

107

812

1.33

2.13

1.6

1.7

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

137

1.83

2.13

1.4

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

152

1.79

2.12

1.4

1.6

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

2.14

2.08

2.2

177.63

147.02

nmol/l

0.48

(3020123) Porphyrins [Interpretation] in Serum or Plasma

5.01

2.07

1.0

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.51

2.01

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

170

1.71

2.00

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1733

17921

0.89

1.98

4.1

3.5

1.34

1.27

mmol/l

3.60

1620

16599

(3004451) EKG impression Narrative

2.03

1.95

1.2

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

179

1.68

1.95

3.7

2.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

404

1.45

1.94

1.5

1.7

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.57

1.94

1.1

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

3.76

1.93

2.0

2.2

119.67

128.50

ug/g

—

(3008898) HLA-B27 [Presence]

105

808

1.31

1.93

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.73

1.93

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.73

1.93

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.73

1.93

1.0

1.1

—

(40758292) HTLV I+II Ab panel - Serum

2.73

1.93

1.0

1.4

—

(3013637) Mi-2 Ab [Presence] in Serum

2.73

1.93

1.0

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

204

1701

1.22

1.91

1.9

1.8

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

760

1.32

1.86

1.5

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

152

1.72

1.83

2.0

1.5

0.91

0.94

g/l

0.21

152

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

407

3615

1.15

1.82

1.6

1.5

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

4.17

1.82

1.0

1.6

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

146

1.72

1.77

1.4

1.3

103.62

167.88

pmol/l

2.49

146

(3000012) Reticulocyte production index

217

1.57

1.73

1.6

1.9

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

482

1.38

1.73

1.4

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

113

893

1.28

1.73

2.1

1.8

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.67

1.72

1.0

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

2.92

1.72

1.4

1.5

6.63

464710.52

nmol/l

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

125

1.77

1.72

1.3

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

340

1.45

1.71

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.06

1.70

1.3

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

854

0.73

1.69

1.4

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

251

2161

1.18

1.69

1.9

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

477

1.37

1.67

1.1

2.54

6.04

u/ml

2.78

266

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.51

1.66

2.6

2.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.59

1.66

2.1

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.80

1.65

1.1

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1136

0.78

1.58

1.5

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.70

1.58

1.1

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

400

3588

1.14

1.56

2.3

2.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

137

1.69

1.55

1.3

1.2

—

(3034426) Prothrombin time (PT)

1.98

1.54

1.2

1.3

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

1.52

0.0

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

258

0.54

1.52

2.7

3.6

19.79

30.77

u/ml

0.69

251

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

1.83

1.51

1.3

1.1

38.76

17.76

u/l

0.75

(3017704) Immunofixation for Urine

1.87

1.50

1.3

1.7

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

1.95

1.48

1.9

1.8

162.71

148.10

0.14

(3052592) Norovirus Ag [Presence] in Stool

2.50

1.45

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.12

1.44

1.9

1.7

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.13

1.44

1.4

5.7

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.73

1.43

1.0

1.2

1.56

1.77

umol/24h

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.73

1.43

1.0

1.1

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

2.73

1.43

1.0

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

196

1.54

1.43

2.3

4.3

—

(1002224) Polysomnography panel

105

847

1.25

1.41

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.00

1.38

1.3

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

2.61

1.36

4.7

6.0

16.00

48.59

ug/min

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.61

1.36

1.8

2.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

391

1.36

4.4

2.6

1.12

0.83

nmol/l

1.48

335

(3032057) Clostridioides difficile [Presence] in Stool

2.36

1.29

1.9

2.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1386

14360

0.92

1.28

3.8

3.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

187

1.50

1.24

1.2

1.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

131

1.61

1.23

1.0

1.2

—

4.83

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

763

0.77

1.22

1.7

—

(3050794) Legionella sp Ab [Presence] in Serum

2.63

1.21

1.4

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.63

1.21

1.0

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

1.80

1.21

1.1

1.2

—

60.00

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

132

1.60

1.20

2.0

1.4

85.43

78.57

umol/l

0.40

132

(3017509) Phencyclidine [Presence] in Urine

2.31

1.18

1.7

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

281

1.39

1.18

1.3

1.6

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

141

1.57

1.17

1.4

1.5

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.00

1.16

1.5

2.3

19.36

16.35

umol/l

—

(3019174) dRVVT (LA screen)

2.50

1.15

1.0

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.00

1.15

0.0

1.3

—

(3011648) Oxygen content in Venous blood

134

1.57

1.14

4.6

3.7

13.35

11.27

1.12

134

(3045462) Protein/Creatinine [Ratio] in Urine

2.34

1.12

3.9

3.5

32.19

40.60

g/mol

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.90

1.12

1.3

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

119

1.60

1.11

1.3

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.38

1.09

2.2

1.7

58.00

128.00

ng/l

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

136

1.55

1.08

1.0

1.1

—

13.67

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

461

1.29

1.08

1.1

0.78

1.48

u/ml

0.67

205

(3044242) Glucose [Moles/volume] in Arterial blood

1.65

1.06

1.9

2.6

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.12

1.05

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.65

1.00

2.7

1.8

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.65

1.00

1.2

1.1

362.37

199.43

iu/ml

0.42

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.65

1.00

2.7

1.8

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

115

1.57

0.99

1.3

1.6

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

164

1.47

0.99

1.5

1.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.67

0.97

4.4

4.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

100

1.60

0.96

1.3

1.6

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.69

0.95

2.1

2.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

338

3102

1.10

0.94

1.6

1.7

—

(3001556) Androgen free Index in Serum or Plasma

2.23

0.93

1.3

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

463

1.26

0.93

1.2

1.1

1.72

1.98

u/ml

0.11

234

(3035880) pH of Pleural fluid

1.67

0.91

1.0

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

176

1.42

0.90

1.0

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1852

18172

1.08

0.89

4.7

4.0

5.89

5.82

mmol/l

1.06

1726

16720

(40765096) Chromosome analysis panel by Banding

1.79

0.87

1.2

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.79

0.87

1.8

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

145

1.45

0.84

1.7

—

(4094501) Cardiovascular stress test using bicycle ergometer

452

1.24

0.83

1.1

—

(40757373) Influenza virus identified in Isolate

1.88

0.81

1.2

2.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.70

0.80

2.4

1.2

—

(44813793) Dust mix specific IgE antibody measurement

139

1.44

0.79

1.1

1.0

—

(3042631) Mycobacterium sp identified in Specimen

225

1.34

0.78

1.7

2.7

—

(3017569) Oxygen content in Arterial blood

1.59

0.78

2.0

2.9

—

(3045142) Bone marrow Pathology biopsy report

191

1.37

0.77

1.1

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

779

1.17

0.77

1.4

1.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

843

0.84

0.76

2.1

2.0

—

(4146454) Self-monitoring of blood glucose

166

1.39

0.75

2.7

2.8

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

578

1.20

0.74

1.4

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

228

2081

1.11

0.74

4.3

4.0

30.98

31.87

0.63

177

1471

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

100

1.50

0.72

1.3

1.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

134

1.42

0.71

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.67

0.68

2.7

1.8

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

401

1.23

0.68

3.3

3.2

25.80

26.11

mg/l

0.02

254

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

119

0.59

0.67

1.0

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

393

1.23

0.67

1.2

1.1

4.72

4.10

u/ml

0.10

184

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

260

0.73

0.66

1.4

1.6

7.96

7.59

mmol/l

0.32

250

(3023430) Cat dander IgE Ab [Units/volume] in Serum

358

1.23

0.65

1.2

1.1

4.78

5.61

u/ml

0.14

143

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

154

1.37

0.65

6.3

4.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

523

1.19

0.65

1.2

1.1

1.85

2.55

u/ml

0.30

274

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

163

1.35

0.64

1.1

2.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

666

0.84

0.64

1.3

1.5

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.55

0.62

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

111

1246

0.89

0.60

2.0

1.7

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

232

0.73

0.59

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

866

1.14

0.58

1.2

1.3

254.63

228.19

miu/ml

0.21

430

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

106

1.42

0.57

4.8

7.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

193

1.30

0.57

1.8

2.1

7.38

20.97

mg/l

—

(3002256) Pathology report gross observation

254

2368

1.08

0.55

1.3

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

1.47

0.54

1.2

1.1

1.64

38.14

u/ml

—

(3020650) Glucose [Presence] in Urine

1.48

0.53

1.3

1.5

—

(3041806) Other cells [#/volume] in Blood by Manual count

125

1.36

0.53

1.8

1.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

160

1.32

0.53

3.2

1.8

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.54

0.53

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

133

0.68

0.51

1.0

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

197

1.27

0.51

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

136

1.33

0.49

2.1

1.8

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

129

1175

1.10

0.49

1.3

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

1.46

0.46

23.3

18.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

164

1.28

0.46

1.1

1.3

1.58

1.68

u/ml

0.02

(40761511) CBC panel - Blood by Automated count

2044

20618

0.95

0.45

20.6

11.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.40

0.42

1.3

1.4

9.03

8.28

ug/l

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.00

0.41

0.0

1.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

2.1

—

43.00

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.00

0.40

0.0

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

490

4721

1.05

0.40

1.7

1.6

1.51

1.38

mmol/l

2.08

428

4006

(3012441) Differential panel - Pleural fluid

168

1.25

0.40

1.5

1.3

—

(40768806) Pleura Pathology biopsy report

168

1.25

0.40

1.4

1.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.37

0.40

2.3

1.8

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

334

1.17

0.39

1.2

1.0

1.14

0.29

u/ml

—

100

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

102

0.69

0.39

1.0

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.34

0.39

1.5

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.34

0.39

1.5

1.7

—

(40765089) Chromosome analysis panel - Blood by G-banded

105

0.67

0.39

1.1

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

428

1.15

0.39

1.6

1.3

2.73

3.73

ug/l

1.06

397

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

316

1.17

0.39

1.1

1.0

2.25

2.24

u/ml

0.01

154

(3014599) Egg white IgE Ab [Units/volume] in Serum

160

1.25

0.38

1.2

1.1

0.72

2.01

u/ml

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

152

1.25

0.37

1.2

1.1

0.83

2.38

u/ml

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.39

0.37

3.4

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.39

0.37

3.4

1.9

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.36

0.36

1.0

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1819

18009

1.04

0.36

17.6

11.3

87.46

86.32

ml/min/173m2

1.20

1574

14707

(3000330) Specific gravity of Urine by Test strip

842

1.10

0.35

3.0

3.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.37

0.34

3.4

1.9

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

407

1.13

0.32

1.6

1.8

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

129

1.24

0.30

1.2

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

213

1.18

0.29

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

441

1.11

0.28

1.4

1.5

69.90

143.76

pmol/l

1.25

430

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.70

0.26

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

0.69

0.26

2.4

2.8

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

263

1.14

0.25

2.9

3.2

0.86

0.83

nmol/l

0.13

202

(3022621) pH of Urine by Test strip

126

1193

1.06

0.23

2.9

2.6

—

(3048879) Bone marrow aspiration report

1.32

0.23

2.4

2.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.27

0.22

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

372

1.10

0.21

1.4

1.7

7589.84

14646.42

e6/l

1.33

277

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

346

0.89

0.21

1.3

1.2

—

(3001729) Color of Synovial fluid

0.00

0.21

0.0

1.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.16

0.21

1.0

1.3

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

145

1.17

0.20

1.1

8.51

9.19

iu/ml

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

868

1.06

0.20

1.6

1.7

4.95

4.25

mg/l

0.27

621

(3034274) Bile acid [Moles/volume] in Serum --fasting

393

1.10

0.20

3.1

2.3

9.57

6.49

umol/l

0.51

288

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

2.5

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.20

0.0

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

183

1.15

0.20

1.1

1.4

2028.14

1959.92

e6/l

0.04

129

(3003740) Influenza virus B Ag [Presence] in Specimen

407

0.91

0.20

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

407

0.91

0.20

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

133

0.83

0.19

1.1

1.3

1.58

1.56

g/l

0.08

133

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

185

1.14

0.18

1.5

1.6

60.92

57.20

0.13

123

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.13

0.17

6.3

3.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.11

0.17

1.6

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.16

0.16

2.3

4.2

—

(3002385) Erythrocyte distribution width [Ratio]

1722

17318

0.98

0.16

24.7

14.7

14.94

14.83

0.15

1709

16981

(3014271) Vancomycin [Susceptibility]

0.75

0.15

2.3

2.6

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

121

1.16

0.15

1.6

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.81

0.14

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2062

20687

0.98

0.13

14.0

9.2

28.78

26.29

u/l

3.16

2008

20006

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

258

2631

0.98

0.11

1.7

1.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

236

2408

0.98

0.11

1.8

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.15

0.10

1.6

2.4

17.67

102.80

ug/l

0.51

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

417

1.06

0.10

2.7

2.3

135.01

137.05

ug/min

0.01

258

(40768443) Skin Pathology biopsy report

712

1.04

0.10

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

187

0.91

0.10

1.2

1.6

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.09

0.09

1.6

1.1

—

(3044941) Cell count panel - Synovial fluid

248

0.93

0.09

1.2

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

145

1.10

0.09

3.5

2.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

155

1.10

0.09

1.1

0.60

3.98

u/ml

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

166

1.08

0.07

1.3

1.1

—

(3045788) Cell count panel - Pleural fluid

147

1.09

0.07

1.1

1.4

—

(40768793) Breast Pathology biopsy report

407

0.96

0.06

1.2

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

467

0.96

0.06

1.9

2.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

414

1.04

0.06

1.6

—

(3049717) Cytology report of Urine Cyto stain

614

0.98

0.04

2.0

2.5

—

(3003694) ABO and Rh group [Type] in Blood

616

6137

1.01

0.03

1.6

—

(3025130) Human papilloma virus identified in Specimen

329

0.97

0.02

2.0

1.7

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

428

0.98

0.01

1.3

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

433

1.02

0.01

1.3

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

166

0.96

0.00

1.2

1.3

309380.00

97979.58

e6/l

—

100

(3021788) Differential panel - Synovial fluid

284

1.02

0.00

1.4

1.6

—

(21494434) Karyotype in Bone marrow

169

1.01

0.00

1.1

1.3

—

(40768795) Lymph node Pathology biopsy report

164

0.98

0.00

1.1

—

(3015183) Erythrocyte sedimentation rate

118

1.02

0.00

3.9

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.85

0.00

1.2

1.1

—

(3024263) Appearance of Synovial fluid

0.95

0.00

1.5

1.4

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.92

-0.00

1.0

1.2

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.00

-0.00

2.4

3.3

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3047189) Immunofixation for 24 hour Urine

0.90

-0.00

1.5

1.4

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.6

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

-0.00

0.0

1.0

—

170.67

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

8.2

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

29.33

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

-0.00

0.0

1.0

—

170.33

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(3013862) HLA-DP [Type]

0.00

-0.00

0.0

1.0

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

-0.00

0.0

1.3

—

(3035933) Granulocytes/100 leukocytes in Blood

0.93

-0.00

7.4

1.4

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

8.0

—

(3009871) Measles virus Ab [Titer] in Serum

0.99

-0.00

1.6

1.7

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

5.8

—

0.24

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_CERCYST and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_CERCYST	3.663 [3.19, 4.21]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.072

During the follow-up period (1.1.1998 — 31.12.2019), 1185 out of 5799 females with G6_CERCYST died.

Males

Parameter	HR [95% CI]	p-value
G6_CERCYST	3.775 [3.36, 4.24]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.013

During the follow-up period (1.1.1998 — 31.12.2019), 2063 out of 6201 males with G6_CERCYST died.

Mortality risk

Mortality risk for people of age

years, who have G6_CERCYST.

N-year risk	Females	Males
1	0.347%	0.85%
5	2.303%	4.934%
10	5.1%	11.518%
15	9.267%	21.045%
20	15.851%	33.472%

Relationships between endpoints

↥

Index endpoint: G6_CERCYST – Cerebral cysts

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Cerebral cysts

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints